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ABSTRACT 
 
Persistent feelings of fatigue are a widespread complaint reported by older adults, and are 
associated with detriments in health and quality of life. Aging is also accompanied by gains in adiposity, 
reductions in physical activity, and loss of lean mass and physical function. This study assessed the 
influences of body composition [adiposity (%Fat) and mineral-free lean mass (MFLM)] and physical 
activity (total and moderate-to-vigorous; MVPA) on fatigue and function in older adults. Furthermore, we 
sought to determine the mediating role of systemic inflammation on these health outcomes. One-hundred 
eighty-two community-dwelling older adults were recruited to participate in this study (age = 69.2±6.7 
years, 98 men, 84 women) Body composition [adiposity (%Fat) and relative muscle mass (Skeletal 
Muscle Index (SMI); appendicular MFLM/ht2
Men and women reported similar levels of fatigue in all dimensions (p > 0.05) with the exception 
of women reporting higher levels of mental fatigue than men (p = 0.05). Adiposity was positively 
correlated with several measures of fatigue (r range = 0.20 to 0.42), whereas PA was inversely associated 
with the same measures of fatigue (r range = 0.18 to 0.37), both of which were not related to mental 
fatigue. CRP, IL-6 and WBC were also related to several dimensions of fatigue (r range = 0.15 to 0.26). 
Compared across PA-adiposity groups, in the absence of an interaction, there was a main effect of PA and 
adiposity on general and physical fatigue (p < 0.05). Regression analyses revealed that the psychosocial 
variables depression and sleep quality and adiposity independently explained variance in general and 
physical fatigue. Adiposity and inflammation are positively related to general and physical fatigue, with 
adiposity remaining a predictor of both dimensions, independent of other associated factors. In addition, 
PA is inversely associated with these same dimensions of fatigue, and is an independent predictor of 
] was quantified via dual-energy X-ray absorptiometry 
(DXA). Physical activity (PA) was assessed by the Physical Activity Scale for the Elderly (PASE), and 
accelerometers were worn to determine total and MVPA. Fasting blood samples were obtained for 
measurement of serum C-reactive protein (CRP), Interleukin-6 (IL-6), the soluble IL-6 receptor (sIL-6R) 
and WBC count. Fatigue was assessed by the Multidimensional Fatigue Inventory (MFI), to determine 
levels of general, physical and mental fatigue as well as reduced activity and motivation. Lower-extremity 
physical function (LEPF) was evaluated by 7-m walk tests, a Timed Up and Go (Up&Go), a 30-second 
chair stand test (30-Chair), a 6-min walk, the Short Physical Performance Battery (SPPB) and the Star-
Excursion Balance Test (STAR). It was hypothesized that 1) women would report higher levels of fatigue 
and have poorer performance of physical function than men, 2) adiposity would be an independent 
predictor of fatigue and LEPF, 3) PA would be inversely related to fatigue and positively with LEPF, and 
4) inflammation would be positively associated with fatigue. Understanding the biological and behavioral 
influences on fatigue and function is imperative for combating health detriments in older adults. 
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mental fatigue. Adiposity, physical activity and inflammation are identified as potential targets for 
reducing fatigue in older adults. 
Men performed better on all LEPF tests than women (all p < 0.05). Unlike all other independent 
variables, MFLM and SMI were not related to any LEPF outcomes. In the absence of a significant 
interaction, main effects for adiposity were found for mobility tests of LEPF, including WALK, Up&Go, 
30-Chair and 6-min walk. There was a main effect of PA on 6-min walk only with greater PA 
corresponding to better performance. On STAR balance tests, an interaction existed for medial, posterior 
and composite reaches (p < 0.05). After accounting for influences of sex, age and number of co-
morbidities, %Fat remained a significant predictor of all mobility measures and the STAR composite, as 
did PA for Up&Go and 6-min walk (all p < 0.05). 
Our results suggest that adiposity is a major determinant of fatigue and both balance and gait-
related physical function in relatively healthy older adults. Physical activity may help to prevent age-
associated fatigue and loss of mobility; however there does not seem to be an added benefit of MVPA.  
Given the high prevalence and associated health detriments of fatigue in older adults, longitudinal 
studies involving reductions in adiposity and increasing physical activity as possible prevention and 
treatment strategies for both fatigue and mobility impairments are warranted. Due to the complexity of 
these relationships, future work should simultaneously assess body composition components, physical 
activity and inflammation to further our understanding the disablement process. Uncovering the key 
influential factors contributing to fatigue and disability is essential for development and implementation 
of effective prevention and treatment strategies. 
 
 
 
iv 
ACKNOWLEDGEMENTS 
Countless thanks to my mentor, Ellen Evans, for her endless support throughout my academic 
development. It was in her undergraduate class that I grew interested in the study of body composition 
and decided to pursue graduate studies. Upon deciding to continue on toward a Ph.D., there was no 
question that Ellen was the advisor I wanted to work with. Her transparency has been a great asset to my 
professional development, and her mentorship has prepared me to think like a scientist (or, just like her). 
Ellen not only allowed me to ride on the PEB, but to take the wheel! 
Thank you to my committee, Dr. Jeff Woods, Dr. Eddie McAuley, and Dr. Robert Dantzer, 
whose expertise has truly enhanced this project, from study design to interpretation and implications of 
the data, as well and my experience in interdisciplinary research.  
I would not have continued my graduate studies were it not for the faculty of James Madison 
University, Judi Flohr, Mike Saunders and Kent Todd, who initiated me into research. Your guidance and 
encouragement to continue this pursuit was invaluable. 
The commitment of the Department of Kinesiology, the University of Illinois and alumni toward 
graduate studies has been a great asset. My development and this project were supported by the Roger 
Morse Most Promising Graduate Student Award, the Roger Morse Outstanding Graduate Student Award, 
the Cureton Research Award, and the Paul D. Doolen Scholarship for the Study of Aging. 
This project could never have been completed without the dedication and reliability of my fellow 
students: Christie, Hannah, Amber, Mina, Dolores, Matt, Stephen, Kellyn, Jenna, Joe, Kimmy, Colleen, 
Kristen, and Amanda. I am also grateful to Lianne, Jackie, Marc and Lisa for their invaluable assistance 
and flexibility. Thanks also to lab-mates and colleagues who have helped me enjoy this process and 
maintain my sanity: Bjossi, Gunn, Mark, Annie, Daina, Abby B., Abby R., Chris, Leah, Steve, and 
especially Vicki. We have truly developed some life-long friendships. Thank you to all of the VIGOR 
participants, who donated their time and energy to this endeavor, and to helping me (finally) graduate.  
 
Finally, thank you to my family, for the unwavering support and encouragement, always.  
 
.  
v 
TABLE OF CONTENTS 
 
CHAPTER 1:  INTRODUCTION………………………………………………………..    1 
1.1 Significance …………………………………………………………………..  1 
1.2 Specific Aims ………………………………………………………………...  2 
1.3 References  …………………………………………………………………..  3 
 
CHAPTER 2:  LITERATURE REVIEW …………………………………………….   5 
2.1 Public Health Significance of Fatigue in Older Adults...……………………..    5 
2.2  Body Composition Changes with Age ………………………………………..  5 
2.3  Causes of Fatigue in Elderly: Role of Obesity & Systemic Inflammation…….   7 
2.4  Physical Activity: An Important Health Behavior to  
       Reduce Fatigue in Older Adults? ………………………………………………   8 
2.5  Sex Disparity, Fatigue, Obesity, Inflammation and Physical Disability………   10 
2.6  Interactions Among Inflammation, Strength, Fatigue, and Physical Function..  10 
2.7  Influence of Fatigue and Inflammation and Cognition………………………..  12 
2.8  Limitations in the Literature: Fatigue, Inflammation and  
      Physical Function in Older Adults …………………………………………….  13 
2.9  Summary ……………………………………………………………………....  17 
2.10 Preliminary Studies …………………………………………………………...  17 
2.11 References …………………………………………………………………….  21 
 
 
CHAPTER 3:  THE ASSOCIATIONS OF ADIPOSITY, PHYSICAL  
ACTIVITY AND INFLAMMATION WITH FATIGUE  
IN OLDER ADULTS …………………………………………………….   26 
3.1 Introduction…………………………………………………………………...   27 
3.2 Materials and Methods…………………………………….…………….…… 27 
3.3 Results………………………………………….……………………………..   31 
3.4 Discussion……………………..………………………………………………   32 
3.5 References…………………………………………………………………….   36 
 
CHAPTER 4:  BODY COMPOSITION AND HABITUAL PHYSICAL ACTIVITY 
  ARE RELATED WITH PERFORMANCE MEASURES OF PHYSICAL 
  FUNCTION IN COMMUNITY-DWELLING OLDER ADULTS …….     47 
4.1 Introduction…………………………………………………………………..   48 
4.2 Materials and Methods…………………………………….………………… 49 
4.3 Results………………………………………….…………………………….   51 
4.4 Discussion……………………..……………………………………………..   52 
4.5 References……………………………………………………………………   54 
 
CHAPTER 5:  SUMMARY AND DISCUSSION……………………………………..... 63 
 
CURRICULUM VITAE……………………………………………………………........   64 
1 
CHAPTER 1 
 
Introduction 
 
1.1  Significance 
F
According to the National Institute of Aging (NIA), ~35 million Americans are over the age of 
65, with estimates suggesting this population will double within 20 years (NIA). Epidemiological data 
indicate that as much as 1/3 of this population, or more than 10 million elderly Americans, have 
disordered body composition, including excess adiposity and inadequate levels of muscle mass which 
directly or indirectly contribute to astronomical health care costs estimated at more than 18 billion 
dollars annually (1). With these changes in the aging demographics, age-related reductions in physical 
function are a primary public health concern. Detriments in physical function are predictive of falls, 
fractures, hospitalizations, cognitive decline, loss of independence and even mortality (2). A more 
comprehensive understanding of factors influencing physical function is imperative for successful 
aging and maintenance of independence in older adults. 
atigue can be categorized as both a performance decrement and a subjective perception. The 
NIH (3) defines fatigue as a perceived lack of physical or mental energy and fatigability as the degree 
of fatigue associated with activity in any dimension (i.e. physical, mental, emotional, and/or social). 
Approximately 50% of older adults report fatigue (4). Notably, among otherwise healthy individuals, 
fatigue has been associated with disability and loss of independence (5), and 
Recent evidence suggests a relationship between obesity, as measured by body mass index 
(BMI), and fatigue (7), which may be potentially mediated by chronic systemic inflammation (8). This 
relation may be augmented in older adults (9) due to relative increases in a) adiposity (10) and b) pro-
inflammatory cytokines (11). Furthermore, higher levels of adiposity have also been linked to reductions 
in lower-extremity physical function (LEPF) and elevated risk for physical disability in the elderly (12). 
Limited evidence suggests that systemic inflammation accelerates loss of muscle mass and is associated 
with frailty (13). Our own data (14) and others (15;16) indicate that older women report greater fatigue 
than their male counterparts. This sex disparity in fatigue aligns with other reports of elevated health risk 
in older women compared to men including obesity, chronic systemic inflammation, and physical 
disability (17).  
is reported as the most 
common cause for restricting activity of all types (6).  
Notably, physical activity is an effective treatment for reducing systemic inflammation in older 
adults (18) and attenuating fatigue in younger adults and cancer patients (19;20); however, the impact of 
physical activity on fatigue in relatively healthy older individuals is unknown. Moreover, the relations 
among weight status, physical activity, inflammation and physical function, fatigability and perceptions 
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of fatigue are unclear. Interdisciplinary research is needed to develop optimal strategies to reduce 
fatigue, preserve function and enhance quality of life in older individuals. In this context, t
 
he 
overarching objective of the proposed research is to evaluate the impact of weight status and habitual 
physical activity on fatigue in relatively healthy older men and women. To achieve this objective, older 
men and women (n=200; 60-85 y) will be recruited stratified on weight status (normal, overweight or 
obese) and physical activity level (sedentary, active) and evaluated for body composition, physical 
activity, LEPF, systemic inflammation and fatigue. In this context, the specific aims are as follows: 
1.2  Specific Aims 
Specific Aim 1:  To determine the relative impact of weight status and habitual physical activity on 
perceptions of fatigue and objectively measured physical function (LEPF, muscle strength and 
endurance), in age- and BMI matched relatively healthy older men and women. We hypothesized that: 1) 
increased BMI would negatively impact both fatigue and physical function in both sexes but to a greater 
degree in women compared to men, 2) habitual physical activity would be associated with reductions in 
perceived fatigue and improved physical function and would attenuate negative effects of adiposity on 
fatigue and function in both sexes, 3) higher perceptions of fatigue would relate inversely to physical 
function. 
 
Specific Aim 2:  To determine the mediating role of systemic inflammation on the relations among weight 
status, habitual physical activity, fatigue and physical function in older men and women. We 
hypothesized that: 1) the favorable impact of habitual physical activity and negative impact of adiposity 
on fatigue would be mediated in part by systemic inflammation, and, 2) the relation between 
inflammation and fatigue would be stronger in women compared to men.   
 
Secondary Aim 1:  To determine the relative influences of disordered body composition (increased 
adiposity with reduced muscle mass) and reduced muscle quality on physical function in older men and 
women. We hypothesized that: 1) increased adiposity would negatively influence physical function, 2) 
low levels of skeletal muscle mass would not directly influence physical function, and 3) habitual 
physical activity would be positively associated with physical function performance.   
 
Summary:  Identification of both physiological and behavioral influences on fatigue, defined multi-
dimensionally, as a means of reducing fatigue and subsequent detriments in function and threats to 
independence will require interdisciplinary scholarship. Given the sex disparity in fatigue and risk of 
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disability, approaches may need to differ in older women and men. Given the increasing prevalence of 
obesity and changing aging demographics, this research agenda has high public health importance. 
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CHAPTER 2 
 
Literature Review 
 
2.1  Public Health Significance of Fatigue in Older Adults 
Fatigue is a widespread complaint reported clinically. Although prevalence estimates vary 
widely, there is a general consensus that 10 - 25% of the general population perceives they are fatigued 
(1;2). Fatigue appears to be much more prevalent in older adults, with some estimates suggesting as many 
as 50% of elderly individuals experience fatigue (3). Importantly, this age group is likely most susceptible 
to the deleterious consequences of fatigue including reductions in physical activity, muscle weakness, and 
cognitive impairments. Among otherwise healthy individuals, fatigue has been associated with depression 
(4), disability and loss of independence (5) and mortality (6). Unlike the fatigue symptoms that typically 
accompany other underlying medical conditions such as cancer, chronic heart failure, or hypothyroidism, 
general fatigue complaints in the elderly often remain unexplained. Older individuals have the added 
challenge of combating this fatigue to complete their activities of daily living to remain independently 
living. As discussed below, body composition, habitual physical activity and chronic systemic 
inflammation are all implicated in the etiology of fatigue in older adults.  
 
2.2  Body Composition Changes with Age 
Normal aging is accompanied by a progressive reduction in lean mass, increases in total adipose 
tissue, increased abdominal adipose tissue accumulation especially in women after menopause, and lipid 
infiltration into the muscle (7;8). However, these alterations in body composition and fat distribution are 
often masked when assessed by BMI as often no substantial change, if any, in BMI appears, due to a 
reduction in muscle mass that accompanies the increase in fat mass (9). A number of studies, including 
those from our lab, have demonstrated an increased discrepancy between BMI and %Fat in the aging 
population (10). 
The public health significance of the detrimental changes in body composition with age is both 
metabolic and functional, with the latter being of increased research and clinical focus. As previously 
explained, identification of the primary determinant of body composition and strength in relation to 
physical function is challenging, and not well understood. With respect to body composition, it is intuitive 
that the interaction between reduced skeletal muscle mass and increased adiposity may have the most 
impact on physical function. That is to say, lower levels of muscle mass may not be problematic if the 
load being carried (i.e., total body mass) is relatively low as well. On the other end of the spectrum, an 
individual with a high level of muscle mass, but a disproportionately elevated total body mass will likely 
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have detriments in function. The somatotype at greatest risk for disability is a frail obese individual 
(relatively low levels of muscle mass in combination with elevated fat mass), which unfortunately 
represents a rapidly growing portion of the population (11). This disordered body composition profile has 
been coined ‘sarcopenic obesity’. Recently, the definitions of sarcopenia and sarcopenic obesity have 
been topics of debate as the definition method selected not only alters the prevalence estimates, but also 
the relation to physical function and risk of disability. The term sarcopenic obesity in particular is a 
relatively new concept (within the last ~5 years).  It has recently been suggested that sarcopenia, 
particularly as it relates to classification of SO, should be determined based on strength rather than muscle 
mass per se. 
A number of potential underlying mechanisms have been suggested for the progressive loss of 
muscle mass and strength with aging, including changes in hormonal status, neuronal changes, 
phenotypic shifts in fiber type, and malnourishment (12). Two factors that have also been speculated, and 
may provide a more direct link between elevated adiposity and reduced muscle mass are physical 
inactivity (13) and chronic inflammation (14;15) (both systemic and in muscle). Thus, these two 
conditions may be pathogenically related. In this regard, there may be a cyclic relation between 
sarcopenia and obesity. Both conditions lead to reductions in physical capacity and function and 
subsequently higher levels of physical inactivity. It is clear, at least theoretically, to see how these 
alterations in body composition may potentiate each other and facilitate detriments in physical function 
and quality of life in older adults. 
Recently, evidence has suggested that simply assessing changes in muscle mass with age does not 
provide an adequate representation of the detriments in physical ability. Perhaps equally important in 
relation to declines in physical functional ability is a reduction in muscle strength and muscle quality. The 
age-related loss of muscle strength was recently termed ‘dynapenia’ from the translation of ‘poverty of 
strength’. This new term was proposed by Clark and Manini in order to differentiate changes in body 
composition, i.e., muscle mass loss, from alterations in muscle strength (12). The aging process is often 
accompanied by a reduction in the association between muscle mass and muscle strength driven in part by 
changes in muscle quality, quantified as leg strength normalized by leg mineral-free lean mass, which has 
been determined to be the most important factor for physical function in obese frail elderly individuals 
(16). Not only are older adults experiencing reductions in muscle mass, but the muscle mass they retain 
has less contractile ability. This reduction in muscle quality is likely multi-faceted and remain 
incompletely characterized. However, there appears to be an inverse relationship between obesity and 
muscle quality (17). Ideal measurements of muscle quality incorporate the measurement of muscle 
physiological cross-sectional area (PCSA), which is directly proportional to maximal force production 
(18). PCSA is influenced substantially by muscle pennation angle. Some evidence suggests that pennation 
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angle is reduced in older adults, thereby effectively decreasing the PCSA and partially accounting for 
reductions in muscle quality (18). This shift in pennation angle and reduction in PCSA is theorized as one 
possible explanation for changes in muscle quality in obesity. Unfortunately, methods to assess these 
parameters are not widely available, are burdensome for participants, and expensive.  
Some evidence also suggests that muscle power, the ability to produce force quickly, may be a 
more important predictor of gait speed than muscle strength (19). Muscle power appears to decline earlier 
in life than does muscle strength, likely due to phenotypic shifts in muscle fiber type and reduced 
contractile properties of the muscle. In terms of fatigue resistance, studies comparing older adults to their 
young counterparts are equivocal. Interestingly, obese individuals experience greater muscle fatigue (or 
reductions in power) with repeated knee extension repetitions when completed voluntarily, with no 
difference when induced via electrical stimulation (17). The possibility exists that there is a reduction in 
central activation in obese individuals, independent of changes in physiologic muscle function. Whether 
this deficit is neural or psychological has not been determined. This paradox between true physiological 
fatigue and psychological perceived effort/fatigue highlights the interplay between different domains of 
fatigue and the difficulty that exists in assessing these components. Several possibilities exist for a 
connection between reduced muscle mass and perceptions of fatigue/energy, including reductions in 
energy availability, reduced capacity to perform work, and an increase in relative workload of a given 
task.  
 
2.3 Causes of Fatigue in Elderly:  Role of Obesity and Systemic Inflammation  
Causes of fatigue are likely multi-faceted, however, several recent studies have identified a higher 
prevalence and severity of reported fatigue in obese individuals (20). This issue is particularly relevant 
given the recent obesity epidemic in the United States (21) and the well established link with several 
chronic diseases including cardiovascular disease, type 2 diabetes mellitus and cancer. Notably, older 
adults are not protected from this epidemic, as the aging process is associated with disordered body 
composition (i.e. greater adiposity and reductions in lean mass) (22) as described in the previous section. 
Obesity is now recognized as a contributing factor to reductions in physical function and frailty in older 
adults (23). Indeed, the most common elderly phenotype in the near future may be a frail obese person at 
high risk for physical disability (11). This disordered body composition in the elderly is intuitively linked 
to fatigue, although this is not well established. Moreover, the link between perceptions of fatigue and 
objectively measured physical functional abilities and muscle fatigability is unstudied and of high 
importance for successful aging. 
It has been suggested that the association between obesity and fatigue may be mediated by 
inflammation (24). The relationship between adiposity, particularly central adiposity, and elevated levels 
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of inflammation is established; however, whether inflammation is the mediator between obesity and 
fatigue remains to be determined. High levels of inflammatory cytokines are known to induce sickness 
behaviors, including lethargy, by directly or indirectly interacting with the central nervous system (25). 
Although recent reports have identified a relationship between inflammation and fatigue in chronic 
disease populations (26), this association remains to be determined in relatively healthy elderly 
individuals. Evidence to the contrary exists in younger adults, demonstrating adiposity as a predictor of 
fatigue, with no association between inflammation and fatigue (27). Because aging is associated with 
chronic low level systemic inflammation (28), it has been speculated that both adiposity and pro-
inflammatory cytokines may contribute to the increased prevalence of fatigue in older individuals 
compared to younger cohorts (29). This theory is partially supported by our recent data that suggests 
inflammation, assessed solely by C-reactive protein (CRP), is a mediator relating obesity to fatigue in this 
population (30). It should be noted that two factors that require consideration when investigating fatigue 
are sleep quality and depression. It is well-established that sleep quality is linked to fatigue (31). 
Depression is also related to reported fatigue (4;32). Moreover, the link between depression and sleep 
disturbance is well established (20). However, the independent contributions of obesity and habitual 
physical activity, sleep disturbance, and depression to fatigue are largely unknown in the elderly.  
 
2.4 Physical Activity: An Important Health Behavior to Reduce Fatigue in Older Adults? 
The importance of habitual physical activity for optimal health status across the lifespan is well 
established. Insufficient levels of physical activity have also been associated with reported fatigue in both 
men and women (33). Recent literature suggests that increasing physical activity may attenuate 
perceptions of fatigue, at least in younger adults and cancer patients (34;35). Little data exist regarding 
the influence of varying levels of habitual physical activity, both activities of daily living and structured 
purposeful exercise, on fatigue, particularly in the elderly. From a mechanistic perspective, accumulating 
evidence has identified an anti-inflammatory effect of exercise (36), which may in turn result in 
subsequent reductions in perceptions of fatigue. Furthermore, regular physical activity has been proven 
effective in counteracting the adverse effects of adiposity on health status (37); however, whether habitual 
physical activity can attenuate fatigue in obese individuals has not been determined.  
 
2.4a Fatigue as a Barrier to Physical Activity 
The detrimental effects of fatigue on quality of life are well established. There are intuitive 
relationships between perceptions of fatigue and psychological well-being. However, what is less 
understood is the degree to which these links are driven by changes in behavior. Lack of energy and 
feeling “too tired” are among the leading reasons/excuses people give as barriers to exercise. A recent 
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survey by Reichert et al. 2007, demonstrated that ~ 38% of the 3000 individuals surveyed reported 
“feeling too tired” was their biggest barrier to exercising. In individuals ≥ 70 years of age, ~43% reported 
this barrier to habitual physical activity (38). Although many benefits to exercise are well established and 
accepted by the general public, physical inactivity remains a major public health concern. Gaining a better 
understanding of the ‘risk factors’ for physical inactivity is critical to determine strategies to elicit 
behavior change.  
The difficulty arises in discerning the interaction between fatigue and physical activity because 
this relationship is likely bi-directional. A substantial quantity of research has demonstrated a causal link 
between physical activity and mood, at least acutely. Exercise appears to produce a bodily state of 
arousal, which creates a feeling of vigor (at least in light to moderate exercise). This acute change in 
perceptions of energy remains for up to several hours following the exercise bout. Theoretically, when an 
individual engages in physical activity they will potentially have a greater perception of energy, which 
may allow them to complete both physical and mental tasks of daily living, including running errands, 
yard-work, cleaning house, balancing the checkbook, etc. Unfortunately, similar to other beneficial health 
parameters influenced acutely and chronically by exercise, this outcome of enhanced energy is 
insufficient in stimulating individuals to exercise in the first place, particularly those having difficulty 
overcoming their feelings of fatigue and tiredness to initiate exercise.  
 
2.4b Importance of Physical Activity for Function and Fatigue 
 Physical activity has been consistently associated with improvements in physical function in 
older adults. These benefits manifest as both a prolonged time until mobility disability occurs in the 
lifespan as well as improvements in functional testing scores. For example, physical activity has been 
shown to improve status [assessed via the short physical performance battery (SPPB)] scores by >1 point 
which has been supported as a clinically meaningful improvement in function (39). A study by Nosek and 
colleagues highlights the interactive effects of disability, fatigue, and psychosocial correlates with 
physical activity. In older women living with disabilities, those experiencing disability for a longer period 
of time report less physical activity. Women with higher levels of self-efficacy for physical activity 
engage in more physical activity, across durations of disability. Additionally, individuals perceiving a 
greater degree of vigor tend to partake in better health related activities, including having better 
nutritional habits (40).  
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2.5 Sex Disparity, Fatigue, Obesity, Inflammation and Physical Disability 
It has also been suggested that women may exhibit a greater degree of fatigue and/or perceptions 
of fatigue, particularly as they age (1;41); however, this finding is equivocal (2;27). Our own data suggest 
that older women have greater perceptions of fatigue (30) and reduced LEPF (42) compared to their male 
counterparts; however, sex differences in fatigue severity and in differing functional domains of fatigue 
(i.e., physical, mental, etc.) in older adults has not been well characterized. There are known sex 
differences in adiposity, habitual physical activity and cardiorespiratory fitness, and systemic 
inflammation that may influence fatigue. Additionally, women report greater levels of depression and 
sleep disturbance in late life (43). The mediating effects of weight status and physical activity on the 
relation between systemic inflammation and reported fatigue and how these relations differ in older men 
and women is inadequately characterized.   
 
2.6 Interactions Among Inflammation, Strength, Fatigue and Physical Function 
 
2.6a Inflammation and Fatigue 
 In young adults, individuals categorized as having insufficient fatigue, that is fatigue not severe 
or persistent enough to be diagnosed with chronic fatigue syndrome, have elevated levels of inflammation 
compared to their non-fatigued counterparts (26). In addition, these individuals report worse physical 
component (PCS) and mental component (MCS) summary scores based on the SF-36. When collapsed 
across fatigue groups, scores on the PCS were higher in subjects with CRP levels above the clinical cut-
off (>3 mg/L) when compared to subjects with CRP <3 mg/L. We aim to determine if these relationships 
exist in an aging population. 
 
2.6b Fatigue and Physical Function 
Although intuitively there is an inverse relationship between fatigue and function, this has not 
been well studied. In a recent study, Hardy and Studenski (2008) assessed ~500 older men and women 
(44% female, 74 yrs) for tiredness (fatigue) (44). Participants were asked if, during the past month, they 
had been “feeling tired most of the time.” Subjects reporting tiredness also rated the degree to which this 
fatigue affected their function. Function was assessed subjectively using the SF-36 physical component 
index and National Health Interview Survey Activities of Daily Living (NHIS) scale and objectively 
using usual gait speed over 4-meters. BMI, GDS, & chronic conditions served as covariates. Tired 
individuals included a higher proportion of females, and reported more chronic conditions, higher 
depression scores, worse subjective function (SF-36 PCS of 50 vs. 74), and had slower usual gait speed 
(0.82 m/s vs 0.92 m/s), but had similar levels of cognitive function. Participants were then followed up for 
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3 years. For all 3 outcomes of function tiredness at baseline was associated with poorer function through 
the follow-up period, but followed similar rates of decline to participants not reporting tiredness at 
baseline. The relation among fatigue and physical function, and the directionality of the relations, remains 
an important public health topic. 
 
2.6c Inflammation, Fatigue and Physical Function 
Due to the detrimental effects fatigue has on function and mobility, there has been increasing 
focus on identifying mediators of this disablement process. Very recently interest has emerged in 
identifying a relationship between chronic inflammation and impairments in physical function. Recently, 
a group at Wake Forest University published a study combining data from four clinical trials, in which 
over 500 older men and women (≥ 55 years) were assessed for grip strength, physical function using the 
SPPB, inflammation (IL-6, TNF-α and CRP), and body composition via DXA (45). Elevated levels of IL-
6 and CRP related to poorer grip strength and SPPB performance scores, independent of disease status. 
These results were not impacted by controlling for lean mass, but were attenuated after controlling for 
adiposity.  
The inverse relationship between adiposity and mobility is well established, as discussed 
previously. Although there is a clear biomechanical component involved in this relationship, it appears 
this is not solely responsible. The possibility exists that inflammation could be mediating this reduction in 
function. Stenholm et al., recently shed light on this mediation (46). This group assessed the risk of 
walking limitation based on self-reported walking difficulty in completing 500 meters and slow maximal 
walking speed (<1.2 m/s). There was an increased risk of walking limitations based on all measures of 
adiposity (BMI, waist circumference and %Fat). In a separate analysis individuals with high CRP levels 
and those with low handgrip strength had more prevalence of walking limitations, but no interaction 
existed between these variables and %Fat. Using logistic regression, CRP was found to be a significant 
explanatory factor in the association between high %Fat and walking limitation.  
Bautmans and colleagues recently sought to examine relations between objectively measured 
strength and muscular endurance in relation to perceptions of fatigue (47). Using a prolonged isometric 
handgrip to identify resistance to fatigue, the researchers identified that better fatigue resistance was 
related to: less self-perceived tiredness, less fatigue during ADLs, and being bothered less by fatigue. 
Furthermore, fatigue resistance was associated with both balance and basic mobility. Fatigue resistance 
was also moderately associated with circulating TNF-α in both males and females (r = -0.45). 
Interestingly, when stratified by high or low inflammatory status, individuals with high IL-6 and high 
Hsp70 had the least fatigue resistance. Findings from this study support both poor muscle endurance and 
elevations in inflammation leading to detriments in function.  
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The most comprehensive analysis to date regarding the influence of fatigue on strength and 
function came from the InCHIANTI study. Vestergaard and colleagues performed a cross-sectional 
analysis on ~1000 older Italian men and women, age 65 and over. In this study they defined fatigue based 
on 2 questions: whether participants felt that “everything was an effort” and/or they “could not get going” 
on three or more days in the past week (48). These items were selected from the Center for Epidemiologic 
Studies-Depression scale (CES-D). Physical function was objectively measured via handgrip strength, the 
SPPB and walking speed during a 400-m walk. Disability was defined as the inability to complete the 
400-m walk or self-reported difficulty in ADL and/or IADL, assessed as any difficulty on any 1 ADL or 
IADL item. Biomarkers were assessed as well, including CRP, IL-6, TNF-a for inflammation, and TSH, 
fT4 and fT3 for thyroid function. Adjusting for age, fatigued men and women had higher prevalence of 
disability in IADL, and poorer performance on all measures of physical function, including the SPPB, 
400-meter walk, and had weaker handgrip strength. Fatigued individuals also reported poorer health, 
sleep quality, and more depressive symptoms. Importantly, fatigue was associated with an increased risk 
of being sedentary in men, and had a tendency to increase risk in women (p = 0.07).  Also notable, 
fatigued men and women had higher CRP levels than non-fatigued, which partially explained the 
relationship between fatigue and function. Of note, the inflammatory status of the participants in this 
study are quite high, with means of both fatigued and non-fatigued men and women well above the 
clinical cut-off in terms of metabolic outcomes (>3mg/L).  
 
2.7 Influence of Fatigue and Inflammation and Cognition 
 
2.7a Fatigue and Cognition 
It is estimated that somewhere between 50-75% of patients with chronic fatigue syndrome (CFS) 
report cognitive impairments, many of which are severe enough to interfere with daily function (49). 
Common cognitive complaints in this population include inability to concentrate, problems with memory, 
slower thought processing, and mental fatigue. However, studies objectively assessing cognitive 
dysfunction in CFS as compared to controls have been equivocal (49;50). Capuron et al. suggest the 
presence of mental fatigue in patients with CFS may explain the heterogeneity of objectively measured 
cognitive dysfunction (49). Along this line, we speculate that increased mental fatigue in an otherwise 
health population will relate to poorer cognitive function.  
The vast majority of studies assessing ‘fatigue’ and cognition has been performed in disease 
populations, such as (CFS), or in response to severely fatiguing stimuli such as INF-γ treatment and acute 
sleep deprivation. As stated previously, studies objectively assessing cognition have provided mixed 
results. However, some evidence exists in support of the measurements of choice reaction time, rapid 
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visual information processing, and aspects of spatial working, spatial recognition, and pattern recognition 
memory (49-51). These tests encompass a variety of different cognitive processes and their use provides a 
comprehensive assessment of the construct of cognition. A review by Lieberman summarized the 
relationship between self-reported mood states and objectively measured ‘mental energy’ via cognitive 
tasks. The literature supports the efficacy of reaction time tasks, choice reaction time tasks in particular, 
and vigilance tasks as measures sensitive to detect differences in mental energy (52). In addition to these 
tasks, rapid visual information processing tasks are recommended as a way to evaluate sustained 
attention, which have also been proven effective in detecting differences in CFS as compared to controls.   
 
2.7b Inflammation and Cognition 
Inflammation has been implicated as a potential contributor to cognitive decline, possibly linking 
with fatigue. Use of a paper-pencil version of the Stroop test in older adults to assess cognition 
demonstrated a moderate association between inflammation and cognitive decline (53). Using more 
sophisticated cognitive testing techniques, Gimeno et al. (2008) also identified a relationship between 
low-grade inflammation and performance in specific domains of cognition (54). When followed up 
however, baseline inflammatory status did not relate to cognitive decline. In a sample of older women, 
CRP was associated with a decline in memory, but not in cognitive speed (55). Taken together, there is a 
growing body of evidence, all of which is very recent, supporting a relationship between inflammation 
and cognition. This area is in its infancy and can benefit from more comprehensive assessments of 
cognition, inflammation and fatigue status. 
 
2.8 Limitations in the Literature: Fatigue, Inflammation and Physical Function in Older Adults 
 
2.8a Conceptualizing Fatigue 
 Assessing the construct of fatigue is challenging as it is a multi-dimensional. There are several 
different domains of fatigue, including physical, mental, emotional, etc. Measurement of the prevalence 
and severity of fatigue often require different instruments. Selection of a measurement tool is equally 
challenging, as there are more than 30 questionnaires developed to measure ‘fatigue’. Unfortunately, each 
scale or set of questionnaires differs slightly. For example, one scale may assess ‘exhaustion’ whereas 
another may attempt to assess ‘lack of energy’. Adding to this complexity is the subjectivity of an 
individual’s perception of fatigue. Each individual’s responses may differ based upon a multitude of 
factors, including the adjectives used in the question, the phrasing of the question, personality traits, etc. 
Even more influential are the external factors that both acutely and chronically impact one’s feelings of 
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energy/fatigue, including work/life stress, family concerns, sleep quality, recent activity, etc. This latter 
idea, also contributes to the measurement of fatigability, or the fatigue created by a given stimulus.  
 
2.8b Comparison of Objective and Subject Measures of Fatigue & Function 
Self-reported fatigue and function is often used as single measures of each construct. What hasn’t 
been well characterized is the relationship between these assessments and objectively measured physical 
function. It is expected that an increase in perceptions of fatigue would relate to poorer performance. 
However, the extent to which perceptual fatigue influences physical function has not been established. 
For example, does a reduction of 2 points on the MFI general fatigue subscale correspond with a 
meaningful improvement in physical activity and function? Mallinson and colleagues performed this type 
of analysis in cancer patients receiving chemotherapy treatment (56). This group assessed motor and 
cognitive functions using both self-report and objective measures. Self-reported and observed data were 
moderately correlated (r = 0.30 to 0.71). Reported fatigue correlated moderately with functional 
performance as well (r = 0.30 to 0.45). The researchers concluded that self-report measures of fatigue and 
function are valuable indicators of objectively measured function. They provide evidence that SF-36 
physical function sub-scores <50 are associated with greater difficulty performing activities of daily 
living. 
From a methodological standpoint, it is important to capture the fatigability of individuals after 
both practical tasks encountered in daily life, as well as to more vigorous stimuli. Furthermore, 
incorporating both types of tasks allows the researcher to assess fatigue relative to an absolute task and to 
tasks equal in relative intensity across individuals. It is theorized that more physically activity and ‘fit’ 
individuals will be less susceptible to fatigue, even at equivalent relative intensities, and that any fatigue 
that is experienced will be to a lesser severity. In contrast, it is speculated that obese individuals may 
experience greater perceptions of fatigue from the same relative stimuli. 
Fatigue following a particular activity is very difficult to quantify. Specifically, in terms of 
performing tasks of daily living and or ‘basic’ functional tasks, less ‘fit’ individuals are working at a 
greater (substantially greater in some instances) relative intensity than their more robust counterparts (57). 
Hypothetically, climbing a flight of stairs has an estimated energy cost of ~ 3 METS. Converting this to a 
VO2 value this is 10 ml/kg/min. For individuals with a VO2max of 15 ml/kg/min they are working at 67% 
of their maximal aerobic capacity (and likely above their lactate threshold).  Conversely, if the 
individual’s VO2max was 25 ml/kg/min, they would only be working at ~40% of the maximal capacity. 
Furthermore, dynamic tasks, such as ascending or descending a flight of stairs rely substantially on 
muscle strength and/or muscle power (of the lower body). Obese individuals must have more strength to 
move their greater load, or will have the inability to perform these types of tasks. From a practical 
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standpoint this is extremely relevant, in terms of one’s ability to carry out activities of daily living, 
however it does pose some methodological concerns. Designing a study that assesses several domains of 
fatigue, including: self-perceptions, muscle fatigue and mental fatigue, as well as in multiple contexts: 
‘normal’ morning levels and following both physical and mental tasks, may provide a better 
understanding of factors influencing fatigue as it relates to changes in behavior. Furthermore, this 
approach may aid in the identification of factors pre-disposing or underlying fatigue in older adults. 
 
2.8c Limitations in the Literature Regarding Body Composition, Function and Fatigue 
Importantly, previous studies that have used this method to categorize “impaired muscle strength” 
have stratified by tertiles of hand grip strength within gender. It is acknowledged that hand grip strength is 
a useful indicator of muscle strength and has been associated with physical function. However, leg 
strength has a stronger association with physical function and is more predictive of disability (7). Future 
studies would benefit from the use of this type of strength assessment in combination with body 
composition methods that accurately assess adiposity (rather than BMI) to categorize sarcopenic-obesity. 
Furthermore, these studies should include a composite of functional tasks to evaluate the individual and 
interactive influences of both impaired muscle strength and obesity on function in older adults. 
In addition to these limitations identified above, according to the NIH focus group regarding 
fatigue in the elderly (58), several questions still exist with regard to body composition and fatigue. These 
“future questions” include: What is the relationship between muscle mass (sarcopenia) and fatigue? What 
is the relationship between adiposity and fatigue? To what extent is the effect of adiposity on fatigue 
mediated by fat mass alone vs. metabolic mediators; for example, adipokines? What is the relationship 
between muscle function and the symptom of fatigue? Can older pre-frail adults serve as a model to 
examine the sequence of events leading to fatigue? What is the role of the central nervous system in 
altered muscle function and symptomatic fatigue?  
Along these lines we propose an additional question that remains to be answered: What is the 
relationship between muscle strength (“dynapenia”) and/or muscle quality (particularly in the lower body) 
and fatigue?  
 
2.8d Summary and Call for Interdisciplinary Approaches to the Study of Fatigue, Inflammation 
and Function in Older Adults 
As stated above, the NIH focus group on fatigue in the elderly identified several unanswered 
questions remaining in this understudied area. In addition to those mentioned previously, those of 
particular interest and relevance to the present study include those related to: 
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Inflammation and the central nervous system:  
• Are there “best markers” for fatigue?  
• Can we develop aggregate inflammatory and HPA axis markers that are most predictive 
of symptoms and adverse outcomes? 
• Can we more appropriately and directly target specific components of inflammatory 
pathways?  
• Can we identify genotypes/phenotypes “at risk” for fatigue and target individuals for 
intervention?  
 
In the psychosocial domain unanswered questions are:  
• Is it more useful for studies to focus on the presence of fatigue or the absence of energy? 
• Can interventions be developed that increase positive affect without costly energy; for 
example, meditation or relaxation?  
 
Finally, in the functional status domain, the following questions remain:  
• Which social, psychological, physiological, or health factors explain the association 
between tiredness and functional decline?  
• Is tiredness related to other indicators of aging, such as biological indicators? Is tiredness 
in midlife related to functional decline in old age?  
• Is the predictive power of measures of function and fatigue the same among different 
ages or between sexes? 
 
Importantly, to date no study has assessed these interacting relationships of strength, fatigue, 
body composition and inflammation using a multi-dimensional fatigue analysis. Furthermore, strength has 
been demonstrated to be an important determinant of functional ability, but has been based solely on 
handgrip strength in these analyses. Inclusion of more direct measures of lower-body strength may 
provide better insight regarding the influence of strength in the context of both fatigue and function. Only 
the study by Vestergaard stratified their analyses by sex. Additionally, although sedentary status was 
controlled for in one study, the effect of physical activity (quantity or intensity), on these outcomes has 
not been evaluated. Given what we now know regarding the anti-inflammatory effect of exercise, 
including physical activity into these models may have important health implications. 
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2.9 Summary 
 The interactive relations among body composition, physical activity, inflammation, physical 
function and fatigue remains to be determined in older adults. Identification of both physiological and 
behavioral influences on fatigue, defined multi-dimensionally, as a means of reducing fatigue and 
subsequent detriments in function and threats to independence will require interdisciplinary scholarship. 
Given the sex disparity in fatigue and risk of disability, approaches may need to differ in older women 
and men. Given the increasing prevalence of obesity and changing aging demographics, this research 
agenda has high public health importance.  
 
2.10   Preliminary Studies 
  The brief summaries below provide evidence of: 1) the scientific rationale for the proposed work 
in this application; 2) the proposed study being a logical extension of our previous work; 3) our ability to 
recruit elderly men and women; 4) our expertise with the methodologies to be utilized; and 5) our well-
rounded and established environment, which allows us to view these issues from an interdisciplinary 
perspective. 
 
2.10a Sex, Adiposity and Inflammation 
Stronger relationship between central adiposity and C-reactive protein in older women than men. 
Valentine RJ, Vieira VJ, Woods JA, Evans EM. Menopause:2009; 16(1):84-9.(59) 
 
Objective and Methods:  The purpose of this study was to determine the sex-specific independent 
relationships between physical activity, fitness, central and whole body adiposity and CRP in sedentary 
older adults (70.0±5.4 years; N=132, 47 men, 85 women). Results and Conclusions: CRP tended to be 
higher in women than men (4.0±2.9 vs. 3.1±2.3 mg/L, p=0.07). All measures of adiposity were positively 
associated with CRP in women (r range=0.22 to 0.28, all p<0.05), whereas neither physical activity nor 
fitness were related. In contrast, %Fat was the only measure of adiposity associated with CRP in men 
(r=0.36, p=0.01) and VO2peak
 
 was inversely correlated to CRP (r=-0.31, p=0.04). Trunk fat was the only 
independent predictor of CRP in women, while %Fat and anti-inflammatory medication use were 
independent predictors of CRP in men. In sedentary healthy older adults the relation between regional 
body fatness, aerobic fitness and CRP differs between sexes such that a) central adiposity was most 
strongly associated with CRP in women, whereas %Fat was the strongest predictor of systemic 
inflammation in men and b) the negative association between fitness and CRP was stronger in men.  
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Figure 2.1 
 
2.10b  Physical Activity, Strength, Body Composition and Physical Function 
Sex impacts the relation between body composition and physical function in older adults. Valentine RJ, 
Misic MM, Rosengren KS, Woods JA, Evans EM. Menopause:2009; 16(3):518-23. (42) 
 
Figure 2.2  
Objective and Methods:  To determine the sex-specific 
relationships between physical activity, aerobic fitness, 
adiposity (%Fat), mineral-free lean mass (MFLM) and 
balance and gait in older adults. Eighty-five female and 49 
male sedentary, healthy, community-dwelling older adults 
(69.6±5.4 and 70.3±4.7 years, respectively) were evaluated 
on habitual physical, aerobic fitness, whole and regional 
body composition, and lower-extremity physical function 
(LEPF) using gait tasks and computerized dynamic 
posturography. Results and Conclusions: Males tended to 
perform better on all LEPF tasks than women (all p≤0.1). 
Physical activity was not related to gait; however, fitness 
was in both sexes (r>0.50, all p<0.05). Body fat was related 
to gait in women (r=-0.38, p<0.05) but not men. In women 
only leg MFLM was positively associated was balance 
(r=0.27, p<0.05). There was an interaction with sex for %Fat 
on gait (p=0.05), and for MFLMLEG on balance (p<0.05). In 
sedentary healthy older adults women are more strongly 
impacted by alterations in body composition. Lower %Fat 
and preservation of lower body lean mass have important 
implications for reducing the risk of physical disability, especially in older women.  
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2.10c Adiposity, Physical Activity, Inflammation and Fatigue 
Sex differences in the relationship between obesity, C-reactive protein, physical activity, depression, sleep 
quality and fatigue in older adults. Valentine RJ, McAuley E , Vieira VJ, Baynard T, Hu L, Evans EM , 
Woods JA. Brain Behav Immunol: 2009; 23(5):643-8. (30) 
 
Objective and Methods: The aim of this study was to assess sex differences in fatigue and the extent to 
which adiposity, physical activity and inflammation relate to fatigue (as assessed by 2 items taken from 
the Chohen-Hoberman Inventory of Physical Symptoms (CHIPS) questionnaire) in sedentary older 
adults. Results and Conclusions: Although similar in age (70 y) and BMI (28.0 kg/m2
physical activity (5.8%), and adiposity (3.9%); 
however, in men, only depression explained variance in 
fatigue (12.0%). CRP was 40% higher and adiposity 
12% higher in women reporting fatigue compared to 
those with no fatigue; no such differences existed in 
men. Obese women perceived a greater degree of 
fatigue than non-obese women, but this was not the 
case in men. Women report more fatigue than men 
which was independently associated with 
inflammation, depression, physical activity and 
adiposity, whereas in men the only independent 
predictor was depression. Strategies to prevent fatigue 
may differ in older women and men, especially with 
regard to inflammation, physical activity and adiposity.  
) women (n = 80) 
reported 63% greater fatigue than men (n = 47). Adiposity (r = 0.44), CRP (r = 0.29), physical activity (r 
= -0.26) and fitness (r = -0.41) were related to fatigue in women (all p < 0.05), but not in men. Depression 
was also related to fatigue in women (r = 0.37), and was the only variable related to fatigue in men (r = 
0.42). In women, fatigue was independently explained (all p < 0.05) by CRP (6.6%), depression (6.3%),  
 
2.10d  Fatigue and Physical Function 
Objective and Methods: To complete a preliminary analysis of an on-going study of 49 older 
adults (70.5 ± 6.2 y, 30 females, 19 males) in which we have been able to collect body composition, 
physical function, physical activity, and fatigue [assessed by the Multidimensional Fatigue Inventory 
(MFI)] measures. Results and Conclusions: Relative body fatness (%Fat) was correlated to general and 
mental fatigue in women (r = 0.39 and 0.44, respectively), and although the association between adiposity 
Figure 2.3 
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and physical fatigue was non-significant in men the strength of the relationship was similar, but likely 
underpowered (r = 0.35, p = 0.15). Overweight and obese individuals reported higher levels of general 
fatigue (9.7 vs. 6.8) and physical fatigue (11.3 vs. 9.9) than those in the normal-weight category (p < 
0.05), however the sample size limited breakdown by obesity class within sex. In contrast to adiposity, 
physical activity was inversely associated with all aspects of fatigue (r range = -0.29 to -0.47). In the 
whole group, the reduced activity subscale was inversely related to normal gait speed (r = -0.33). In 
women, general fatigue, reduced activity, and reduced motivation all corresponded to slower gait and 
worse performance on the timed up-and-go (r range = 0.38 to 0.47), whereas no relationship was apparent 
in men. Thus, these cross-sectional data appear to be supportive of our position that both physical activity 
and body composition are implicated in fatigue, and severity of fatigue and may have relevance for 
physical function. Moreover, these relationships may differ in older men and women.  
 
Adiposity and Physical Activity Influence Physical Function and Fatigue in Older Women. Valentine RJ, 
Guest DD, McAuley E, Evans EM. Med Sci Sports Exer: 2010; 42(5):565. (60) 
 
Objective and Methods: Both physical activity and adiposity have been associated with functional 
performance and fatigue in the elderly; however, the relative impact of each is not established. The aim of 
this study was to examine the independent contributions of physical activity and adiposity on physical 
function and fatigue in older community-dwelling women (N = 43; 69.7±6.1 yr). Assessments included 
physical performance via 7-m obstacle walk (7-OB), chair stand (CHAIR) and 6 min walk (WALK); 
general, physical and mental fatigue via the Multidimensional Fatigue Inventory (MFI); physical activity 
by weekly pedometer count (STEPS); and adiposity (%Fat) by DEXA. Results and Conclusions: As 
expected, an inverse relationship existed between STEPS and %Fat (r=-0.38, p=0.01) and greater STEPS 
improved 7-OB, CHAIR and WALK performance (r range=0.42 to 0.51, p<0.01). Greater adiposity was 
associated with poorer 7-OB (r=0.43, p=0.004) and WALK (r=0.52, p<0.001) performance. Similarly, 
greater %Fat was associated with higher general fatigue (r=0.30, p=0.049) and mental fatigue (r=0.31, 
p=0.045) but not physical fatigue (p=0.43). STEPS were related to general fatigue (r=-0.32, p=0.04) but 
not physical or mental fatigue (p>0.05). Hierarchical multiple regression analyses were conducted to 
determine the independent contribution of %Fat and STEPS to 7-OB, WALK and general fatigue. Greater 
adiposity (β=0.32) and fewer STEPS (β=-0.31) were associated with poorer 7-OB (R2=0.27, p=0.002) and 
WALK performance (R2=0.37, p<0.001; β=-0.36 and 0.38, respectively). However, only %Fat (β=0.30) 
was an independent positive predictor of fatigue (p=0.049, R2=0.09). Physical function performance is 
influenced by adiposity and habitual physical activity; however, adiposity is the primary predictor of 
general fatigue in older women.  
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2.10e Summary:  The preliminary data that the PI and research team has assembled to date is well 
aligned with the research questions in the proposed project. Indeed, the specific aims of the proposed 
project are the next step in this line of inquiry. Whereas each of these pieces has been investigated, no 
single study has captured these variables, along with lean body mass, muscle strength and quality in an 
attempt to identify the physiological and behavior mediators of fatigue as well as the translational 
consequences fatigue places on function and independence. 
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CHAPTER 3 
The Associations of Adiposity, Physical Activity and Inflammation  
With Fatigue in Older  Adults 
Abstract 
Persistent feelings of fatigue are a widespread complaint reported by older adults, and are associated with 
detriments in health and quality of life. Purpose: The aim of this study was to determine the influence of 
weight status, habitual physical activity and inflammation on perceptions of fatigue in relatively healthy 
older adults. Methods: One-hundred eighty-two older men and women (age = 69.2±6.7 years, 98 men, 84 
women) were assessed for adiposity (body mass index (BMI) and percent fat via dual-energy X-ray 
absorptiometry, physical activity (PA) using accelerometers, systemic inflammation via serum C-reactive 
protein (CRP), Interleukin-6 (IL-6), sIL-6R and WBC count, and fatigue according to the 
Multidimensional Fatigue Inventory (MFI). Results: Men and women reported similar levels of fatigue in 
all dimensions (p > 0.05) with the exception of women reporting higher levels of mental fatigue than men 
(p = 0.049). Adiposity was positively correlated with fatigue (r range = 0.20 to 0.42), whereas PA was 
inversely associated with fatigue (r range = 0.18 to 0.37), both of which were not related to mental 
fatigue. CRP, IL-6 and WBC were also related to several dimensions of fatigue (r range = 0.15 to 0.26). 
Compared across PA-adiposity groups, there was a main effect of PA and adiposity on general and 
physical fatigue (p < 0.05). Regression analyses revealed that the psychosocial variables depression and 
sleep quality and adiposity independently explained variance in general and physical fatigue. Conclusion: 
Adiposity and inflammation are positively related to general and physical fatigue, with adiposity 
remaining, independent of other associated factors. In addition, PA is inversely associated with these 
same dimensions of fatigue, and is an independent predictor of mental fatigue. Adiposity, physical 
activity and inflammation are identified as potential targets for reducing fatigue in older adults.   
 
Key Words:  fatigue, adiposity, inflammation, depression, physical activity 
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3.1  Introduction 
 Persistent feelings of fatigue are a widespread complaint reported by older adults. Prevalence 
estimates for fatigue range from 10% to upwards of 50% in the elderly population (1;2)). Detriments 
associated with fatigue include, but are not limited to, cardiovascular disease (3), depression (4), and 
mortality (5). Furthermore, among otherwise healthy individuals, fatigue has been associated with 
disability and loss of independence (6), and is reported as the most common cause for restricting activity 
of all types (7). 
 Recent evidence suggests a relationship between obesity, as measured by body mass index 
(BMI), and fatigue (8), which may be potentially mediated by chronic systemic inflammation (9). This 
relation may be augmented in older adults (10) due to age-related increases in a) adiposity (11), b) pro-
inflammatory cytokines (12) and c) reductions in physical activity. 
 The importance of habitual physical activity for optimal health status across the lifespan is well 
established. Notably, physical activity is an effective treatment for reducing systemic inflammation in 
older adults (13).  Insufficient levels of physical activity have also been associated with reported fatigue 
in both men and women (14). Recent literature suggests that increasing physical activity may attenuate 
perceptions of fatigue, at least in younger adults and cancer patients (15;16). Little data exist regarding 
the influence of varying levels of habitual physical activity on fatigue in the elderly. Regular physical 
activity has been proven effective in attenuating  the adverse effects of adiposity on health status (17); 
however, whether habitual physical activity can alleviate fatigue in obese individuals has not been 
determined.  
Moreover, the relations among weight status, physical activity, inflammation and perceptions of 
fatigue are unclear. Interdisciplinary research is needed to develop optimal strategies to reduce fatigue, 
preserve function and enhance quality of life in older individuals. In this context, the primary objective of 
the present study was to evaluate the influence of adiposity, habitual physical activity and systemic 
inflammation on fatigue in relatively healthy older men and women. It was hypothesized that 1) women 
would report higher levels of fatigue than me, 2) adiposity would be a predictor of fatigue, 3) PA would 
be inversely related to fatigue, and 4) inflammation would be positively associated with fatigue. 
Understanding the biological and behavioral influences on fatigue is imperative for combating these 
detriments in older adults. 
 
3.2  Materials and Methods 
Participants 
One hundred eighty-two community-dwelling older adults between the ages of 60 and 85 (84 
women, 98 men; 69.2±6.7 years) participated in this study. Exclusion criteria included the presence of 
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severe arthritis, human immunodeficiency virus, smoking, current diagnoses of inflammatory disease or 
cancer, uncontrolled metabolic or cardiovascular disease, and current use of medications that could 
influence immune measurements (e.g., corticosteroids). All women were post-menopausal.  Participants 
taking anti-inflammatory medications, medications for depression and statins were included in the study 
and use was controlled for statistically (see Table 3.2 for medication usage). Following eligibility 
screening all participants completed a university Institutional Review Board approved informed consent 
prior to enrollment in the study. 
 
Physical Activity 
 Physical activity was determined using the Physical Activity Scale for the Elderly (PASE) (18), 
which estimates the total level of household, occupational and leisure-time physical activities over the 
past month. Accelerometers (ActiGraph single-axis model, Health One Technology) were used to provide 
an objective measure of physical activity over 1 week. Participants were instructed to wear the monitor on 
the non-dominant hip, under clothing, and fastened to a belt worn around the waist. Valid days for 
accelerometer data were determined by 10 hours of wear time during the waking hours (19), defined as 
the moment upon getting out of bed in the morning through the moment of getting into bed in the 
evening. We considered the data to be spurious when counts exceed 20,000 per minute (19), and required 
that participants had five valid days of data for a reliable estimate of weekly physical activity. 
 
 Body Composition 
 Standing height and weight measurements were completed with subjects wearing light-weight 
clothing and no shoes. Height was obtained using a stadiometer (Seca, Model 242) with measures 
obtained to the nearest 0.1 cm. Weight was measured on a calibrated digital scale (Tanita, Model BWB-
627A). Whole-body and regional soft tissue composition was measured by dual-energy X-ray 
absorptiometry (DXA) using a Hologic Discovery A bone densitometer (software version 12.7.3). This 
software allows isolation of specific regions of interest (ROI), and abdominal fat mass was quantified as a 
region from L1-L4 to provide a proxy for central adiposity. Precision for DXA measurements of interest 
are ~ 1-1.5% in our laboratory. Body Mass Index (BMI) was calculated by dividing body mass (kg) by 
height (m) squared [(kg)/ht(m)2
 
]. 
 Fatigue 
 Fatigue was measured by completion of the Multidimensional Fatigue Inventory (MFI; (20)). The 
MFI is used to capture five distinct dimensions of fatigue experienced “lately”, including: general fatigue, 
physical fatigue, mental fatigue, and perceptions of reduced motivation and reduced activity. In each of 
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the five subscales, scores range from 4-20, with higher scores indicating greater fatigue. In order to 
minimize confounding factors imposed by diurnal variation, this questionnaire was completed on the 
morning of the blood draw. Internal consistency for the MFI subscales was good (α = .82), suggesting the 
five domains adequately reflect a single construct.  
 
Sleep, Depression and Stress 
Participants also completed the Pittsburgh Sleep Quality Index (PSQI) (21). The PSQI is a 19-
item instrument reflecting overall sleep quantity and quality over the past month, with higher scores 
reflecting poorer sleep quality. Depression was assessed by the Geriatric Depression Scale (GDS; (22), a 
30-item mood scale, assessing how an individual has felt over the past week. Scores on this scale range 
from 0 to 30, with higher scores corresponding to greater levels of depression. Finally, the Perceived 
Stress Scale (PSS; (23)) was completed to assess perceived stress. The PSS ranges from 0-40, with higher 
scores representing a higher level of stress. Each scale had good internal consistencies (all Cronbach α > 
.80). The GDS, PSQI and PSS all have well-established psychometric properties. 
 
 Systemic Inflammation 
Following an overnight fast, venous blood samples were drawn from an antecubital vein into 
EDTA or serum separator tubes for plasma and serum, respectively. Serum tubes were allowed to clot for 
20-30 min while plasma tubes remained on ice, and all tubes were centrifuged at 1200 x g for 15 minutes 
at 4°C and serum and plasma were stored at -80°C until analysis. Several measures of systemic 
inflammation were assessed, including CRP (hs-CRP), IL-6 (hs-IL-6), and sIL-6R using commercially 
available ELISA kits (R & D Systems, Minneapolis, MN). Our intra-assay CV was determined to be 
<10% across the range of concentrations. The functional sensitivity of the assay was determined by the 
manufacturer to be 0.1mg/l, 0.04 pg/ml and 6.5 pg/ml for CRP, IL-6, and sIL-6R, respectively.  
Inclusion of multiple markers is useful to substantiate inflammatory analyses. Furthermore, these 
markers in particular provide both acute phase protein and innate immune cytokine analyses, and have 
been successfully used to assess immune responses in behavioral disorders (24). Participants were queried 
regarding any acute illnesses during the 48-hours prior to the blood draw and again one week following 
this laboratory visit to ensure inflammatory status was not falsely elevated. CRP values >12 mg/L, 
indicative of acute illness, were eliminated (N = 2). In addition to inflammatory markers, a CBC profile 
was completed on whole blood to screen for illness, evaluate anemia (low Hemoglobin), and white blood 
cell (WBC) counts were used as a marker of inflammation. 
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Statistical Analyses 
Data were analyzed with PASW for Windows version 18.0 (SPSS, Inc., Chicago IL). Means and 
standard deviations were calculated for all participant characteristics and primary outcome variables, and 
distribution statistics were computed to ensure data were normally distributed. CRP and IL-6 were non-
normally distributed and were log transformed, using log base 10, which normalized the data. The non-
transformed CRP and IL-6 values are presented in tables, figures, and text to enhance readability and 
clarity. Independent-samples t-tests were used to examine sex differences in variables of interest. The 
Mann-Whitney U Test was used to test for differences in categorical variables, including co-morbidities 
and medication use between sexes. 
Partial correlation analyses, controlling for sex and age, were used to examine the relations 
between physical activity, fatness, inflammation and fatigue. To further evaluate the influences of 
adiposity and physical activity status on fatigue, participants were categorized based upon BMI: normal 
weight (18 < BMI < 24.9), overweight (BMI > 25.0) and obese (BMI > 30.0). High- and low-activity 
groups were created based on median division, using average accelerometer counts/min, as no standard 
cutoffs have been defined for older adults. The main effects of physical activity and fatness and the 
presence of PA-fatness interactions on fatigue were determined using two-way ANCOVA, adjusting for 
age and sex. Analysis of variance (ANOVA), with post hoc Tukey, was performed to assess differences in 
fatigue status between activity-fatness groups.  
To test whether physical activity, adiposity, and inflammation, as well as psychosocial variables, 
were independently related to fatigue, we conducted a series of hierarchical linear regression (HLR) 
analyses. All analyses were controlled for sex and age, prior to entering other factors into the model. 
Secondly, we controlled for use of medications known to influence inflammation and/or fatigue, 
including anti-inflammatories (aspirin and NSAIDs), statins, β-blockers, calcium-channel blockers, and 
selective serotonin reuptake inhibitors (SSRIs). We next accounted for the number of co-morbid 
conditions present out of the following list: including cardiovascular disease, pulmonary disease, arthritis, 
anemia, diabetes, sleep apnea, and cancer history. Next, we entered psychosocial variables, including 
sleep quality (PSQI), depression (GDS), and perceived stress (PSS) into the model, to control for these 
influences on fatigue. As the primary objective of the present study was to evaluate the contributions of 
behavioral and physiologic factors on fatigue, these factors were entered into the model last, to control for 
all other covariates first, and test for the independent contribution of these factors on fatigue. 
Corresponding to the proposed hypothesis, these were entered in the following order: adiposity (% Body 
Fat), physical activity, and inflammation (CRP, IL-6, sIL-6R and WBC). All significance tests were 
conducted at the p < 0.05 level. 
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3.3  Results 
 Subject characteristics are presented in Table 3.1. Men and women were similar in age and 
BMI, but differed in prevalence of CVD and arthritis, with men reporting higher prevalence of these co-
morbidities, as well as aspirin and statin use (Table 3.2). As expected, women were shorter and lighter, 
and had greater adiposity (%Fat) than men (all p < 0.05). There were no differences in global sleep 
quality, depression, or fatigue between men and women, with the exception of mental fatigue, with 
women reporting higher levels (p<0.05). Women had higher levels of sIL-6R (p<0.05), but did not differ 
in CRP (p=0.06) or IL-6 (p>0.1).  
 
Physiologic and Psychosocial Variables Associated With Fatigue 
Partial correlations for the associations of adiposity, physical activity, inflammation, psycho-
social factors and fatigue, controlling for sex and age, are shown in Table 3.3. Adiposity was related to 
general fatigue, physical fatigue, and reduced activity (r range = 0.21 to 0.42, all p< 0.05). Similarly, 
physical activity (PASE and accelerometer counts) was inversely associated with all dimensions of 
fatigue, except for mental fatigue (r range = -0.18 to -0.37, all p < 0.05). Sleep quality, depression scores 
and perceived stress were each related to fatigue as well. Circulating levels of CRP and IL-6 were 
positively associated with general and physical fatigue (r range = 0.17 to 0.26), whereas sIL-6R was not 
related to any dimensions of fatigue. WBC count was related to physical fatigue and reduced motivation 
(r = 0.22 and 0.21, respectively). 
 
Relations Between Physiologic and Psychosocial Variables 
 After controlling for the influence of age and sex, physical activity was inversely related to 
measures of adiposity (r range = -0.30 to -0.39; Table 3.4), and depression (PASE, r = -0.18). Both 
adiposity and physical activity were associated with inflammatory markers. Adiposity was not related to 
any psychosocial measures. Psychosocial variables were all related to one another, but were not correlated 
with inflammation, with the exception of sleep quality and perceived stress with WBC (r = 0.19 and 0.18, 
respectively). Inflammatory markers, except for sIL-6R, were all inter-related (r range = 0.27 to 0.45). 
 
Physical Activity and Adiposity on Fatigue 
Results comparing fatigue across activity-fatness groups are shown in Figure 3.1. No interactions 
existed between activity and adiposity on component of fatigue (all p > 0.5). There was a main effect of 
adiposity status on general and physical fatigue (p = 0.02 and p < 0.01, respectively). There was also a 
main effect of activity status on general and physical fatigue and reduced activity (p = 0.04, p < 0.01, p = 
0.04, respectively). There was no effect of either adiposity or activity status on reduced motivation or 
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mental fatigue. These relationships remained when controlling for depression, sleep quality, stress and 
medication usage (data not shown). 
 
 Influence of Inflammation on Fatigue 
To further characterize contributions to fatigue, we compared individuals reporting lower levels 
of general fatigue (general fatigue <10 on the 20-point scale) to those with higher levels of fatigue. CRP 
and IL-6 were 58% and 29% higher in individuals with higher levels of fatigue than low-fatigued 
individuals (see Figure 3.2; p < 0.05). 
 
Independent Predictors of Fatigue 
 The independent contribution of adiposity, physical activity and inflammation on dimensions of 
fatigue were evaluated by a series of hierarchical linear regression analyses (Table 3.5). Sleep quality, 
depression and adiposity were all independent predictors of general fatigue, physical fatigue, and reduced 
activity after controlling for all other covariates. Sex was an independent predictor of general fatigue, 
physical fatigue and reduced activity whereas age was an independent predictor of reduced activity. Only 
sleep quality and depression were independently associated with reduced motivation. Independent 
predictors of mental fatigue were age, statin use, depression, and physical activity.  
 
3.4  Discussion 
 This study represents an examination of the relations among adiposity, physical activity, systemic 
inflammation and fatigue in a community sample of older adults. To our knowledge, the influences of 
body composition, physical activity, and inflammation on different dimensions of fatigue has not been 
previously evaluated in healthy community-dwelling older adults.  The major novel findings of this study 
are: 1) adiposity was associated with several aspects of fatigue, including general fatigue, physical 
fatigue, and reduced activity, independent of other related risk factors, such as depressive symptoms, 
sleep quality, perceived stress and physical activity, 2) physical activity was inversely related to most 
dimensions of fatigue, and independently predicted mental fatigue, and 3) inflammation was correlated 
with several dimensions of fatigue; however, this relationship was not independent of other related 
variables.  In the present study, fatigue was assessed by the Multidimensional Fatigue Inventory (MFI). 
The utility of this instrument is the ability to assess five different fatigue domains.  
Contrary to our hypothesis we found no significant sex disparity in fatigue (with the exception of 
mental fatigue). It has been suggested that women may exhibit a greater degree of fatigue and/or 
perceptions of fatigue, particularly as they age (1;25); however, this finding is equivocal (2;26). The use 
of the MFI provided an assessment of fatigue severity rather than the presence or absence of fatigue, 
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precluding the determination of prevalence rates obtained using dichotomous variables of reported fatigue 
or no fatigue. The lack of sex-differences in fatigue status is in support of results from Corwin and 
colleagues who found similar levels of fatigue in younger men and women using the MFI (27). Sex 
differences in fatigue severity and in differing functional domains of fatigue (i.e., physical, mental, etc.) 
in older adults have not been well characterized. Indeed, after controlling for other factors, sex did make 
an independent contribution to general fatigue, physical fatigue, and reduced activity, with being male 
associated with higher levels of fatigue.  
The relationship between adiposity status and fatigue appears to be fairly robust, with %Fat 
remaining a predictor of fatigue in older adults, even after accounting for other contributors (see Table 
3.5). This appears particularly true for physical fatigue, as within the low-activity sub-group normal-
weight individuals report less fatigue than overweight individuals (Figure 3.1). Recently, the American 
Geriatrics Society and the National Institute on Aging held a research conference for “Idiopathic Fatigue 
and Aging” (29). With specific focus on physical fatigue, researchers identified likely contributors, 
including oxidative stress, inflammation, mitochondrial function and energy utilization (28). In regard to 
energy utilization at the whole body level, it was proposed that there is a fixed, limited level of energy 
availability based primarily on aerobic fitness. With age, declines in fitness result in reductions in total 
energy, while completion of activities of daily living requires greater energy due to changes in 
biomechanical efficiency. It is speculated that energy imbalance results in the perception of physical 
fatigue (28). Interestingly, each of the hypothesized mechanisms for physical fatigue is also applicable to 
obesity, as obesity is associated with increases in inflammation (29), oxidative stress (30), mitochondrial 
dysfunction (31), and biomechanical inefficiency during daily tasks (32), as well as reductions in aerobic 
fitness. Coupled together, these age and adiposity related changes clearly place the obese elderly at 
greater risk for fatigue. 
Several research groups have examined the relationship between systemic inflammation and 
fatigue, however this has been mainly limited to clinical populations, such as cancer and chronic fatigue 
syndrome (CFS) (33;34), or younger individuals (27;35;36), with limited evidence regarding this 
association in the general aging population. Some reports have failed to find differences in IL-6 between 
fatigue groups, such as individuals with CFS compared to healthy counter-parts (34), or between CRP and 
somatic symptoms (37). The sparse evidence supporting a relation between inflammation and fatigue in 
healthy humans has been primarily obtained from single-item questions to assess perceived fatigue and/or 
energy (38;39) and fatigue has often been evaluated as a dichotomous variable, i.e., the presence or 
absence of fatigue, rather than the degree of fatigue. We aimed to expand upon previous findings by 
providing a more comprehensive appraisal of fatigue, by assessing multiple dimensions of fatigue. In 
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addition, most previous work in this area has been limited to primarily sedentary individuals (38), 
precluding the ability to detect the influence of varying physical activity levels on fatigue.  
Insufficient levels of physical activity have also been associated with reported fatigue in both men 
and women (14), and subsequently, increased physical activity may attenuate perceptions of fatigue, at 
least in younger adults and cancer patients (15;16). Our data extend this inverse relationship between 
physical activity and fatigue to older adults, even in the presence of higher levels of adiposity. This 
relationship is likely bi-directional, as fatigue is reported as one of, if not the most important reason for 
restricting physical activity, particularly in older adults (7;40). Notably however, there is compelling 
evidence that physical activity lessens feelings of fatigue. Speculated links between physical activity and 
fatigue include: the anti-inflammatory effect of exercise (13), the influence of physical activity on self-
efficacy (41), or the effectiveness of physical activity mitigating the adverse effects of adiposity on 
fatigue, similar to other health hazards (17).  
Our data corroborate previous reports in other populations (33), as both CRP and IL-6 were 
associated with fatigue and other somatic symptoms in relatively healthy older adults (38;42;43). 
Furthermore, individuals reporting higher levels of fatigue also had greater systemic inflammation, 
represented by higher concentrations of CRP and IL-6. Whether a threshold exists, whereby systemic 
inflammation exceeding a specific concentration increases perceptions of fatigue, similar to the clinical 
cutoff of 3.0 mg/l for CRP and cardiovascular disease (44), has not yet been established. In the present 
study, inflammation was not an independent predictor of any dimension of fatigue when controlling for 
other related factors. Lim and colleagues used a similar approach in evaluating the relations among 
adiposity, inflammation, depression and multiple dimensions of fatigue in a young adult population (mean 
age 36 yr) (26). Our results are similar, as their group also found an independent contribution of 
depression on all dimensions of fatigue, and of adiposity on general and physical fatigue as well as vigor. 
Consistent with our results, inflammation did not make an independent contribution on fatigue in young 
adults (26). Interestingly, in contrast to a growing body of literature establishing a relationship between 
inflammation and depression (45), our data do not support an association between adiposity or 
inflammation with depression (see Table 3.4).This lack of relation between inflammation and depression 
may explain the divergent results from the current study and other published work.  
It should be noted, that the inflammatory measures in the current study were captured from a 
single blood-draw at a single time-point. Most circulating inflammatory markers vary according to 
circadian rhythms (46), and levels can be influenced acutely by a variety of means, such as accumulated 
or recent sleep deprivation (47;48), and stress (49). However, the validated questionnaires used to assess 
psychosocial variables are related to longer states, including lately (MFI), in the past week (GDS), or 
during the past month (PSQI). Therefore, these series of questionnaires may not reflect very recent 
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occurrences, such as a night of poor sleep, which may affect reported fatigue. It is also possible that the 
cross-sectional snapshot of this relationship does not account for the long-term consequences of chronic 
low-grade systemic inflammation. Cho and colleagues recently demonstrated, prospectively, a significant 
association between baseline CRP concentrations and fatigue levels at a fifteen year follow-up in younger 
individuals (36). Longitudinal studies evaluating the interactions of physical activity, adiposity and 
inflammation with fatigue are merited.  
The present study is not without further limitations. First, our study included relatively healthy 
community-dwelling older adults. In order to maintain a balance between internal and external validity 
exclusion criteria were limited to diseases and/or medication usage that are known to substantially alter 
immune function or fatigue status. Furthermore, our study sample resembles that of the general 
population, with similar prevalence to national averages in several co-morbidities, including arthritis 
(49% vs. 50%), diabetes (6% vs. 8%), and heart disease (10% vs. 12%) for our data and national 
averages, respectively. We have elected to statistically control for covariates rather than exclude based on 
them, which would substantially impact external validity. Thus, our results may not extend to other 
populations with more severe and/or additional co-morbidities. Secondly, the markers used to assess 
systemic inflammatory status are not exhaustive, and anti-inflammatory cytokines were not evaluated. 
However, the balance between  pro- and anti-inflammatory cytokines may have important relevance in 
relation to fatigue. Similarly, the link between inflammatory cytokines and sickness behavior is through 
the central nervous system (50), which cannot be assessed solely by systemic inflammation. Finally and 
importantly, the cross-sectional design of the current study precludes any inference regarding causality. 
In conclusion, in relatively healthy older adults, women and men report similar levels of fatigue. 
Sleep quality, depression symptoms and perceived stress all influence fatigue status in both sexes. 
However, after accounting for these psycho-social influences adiposity, physical activity, and markers of 
inflammation were all associated with fatigue. Both lower classification of obesity status and higher 
levels of physical activity beneficially influence fatigue. Results suggest that increasing the physical 
activity levels of older adults may have important implications for reducing their levels of fatigue, even in 
the presence of obesity. Given the high prevalence and associated health detriments of fatigue in older 
adults, longitudinal studies involving reductions in adiposity and increasing physical activity as possible 
prevention and treatment strategies are warranted.  
 
36 
3.5 References 
 
 1.  Chen MK. The epidemiology of self-perceived fatigue among adults. Prev Med 1986;15:74-81. 
 2.  Hyyppa MT, Lindholm T, Lehtinen V, et al. Self-perceived fatigue and cortisol secretion in a 
community sample. J Psychosom Res 1993;37:589-594. 
 3.  Rockwood K, Davis HS, Merry HR, et al. Sleep disturbances and mortality: Results from the 
Canadian Study of Health and Aging. J Am Geriatr Soc 2001;49:639-641. 
 4.  Bixler EO, Vgontzas AN, Lin HM, et al. Excessive daytime sleepiness in a general population 
sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 
2005;90:4510-4515. 
 5.  Wingard DL, Berkman LF. Mortality risk associated with sleeping patterns among adults. Sleep 
1983;6:102-107. 
 6.  Liao S, Ferrell BA. Fatigue in an older population. J Am Geriatr Soc 2000;48:426-430. 
 7.  Gill TM, Desai MM, Gahbauer EA, et al. Restricted activity among community-living older 
persons: incidence, precipitants, and health care utilization. Ann Intern Med 2001;135:313-321. 
 8.  Vgontzas AN, Bixler EO, Chrousos GP. Obesity-related sleepiness and fatigue: the role of the 
stress system and cytokines. Ann N Y Acad Sci 2006;1083:329-344. 
 9.  Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of 
excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 
1997;82:1313-1316. 
 10.  Florez H, Troen BR. Fat and inflammaging: a dual path to unfitness in elderly people? J Am Geriatr 
Soc 2008;56:558-560. 
 11.  Kyle UG, Genton L, Hans D, et al. Age-related differences in fat-free mass, skeletal muscle, body 
cell mass and fat mass between 18 and 94 years. Eur J Clin Nutr 2001;55:663-672. 
 12.  Poluri A, Mores J, Cook DB, et al. Fatigue in the elderly population. Phys Med Rehabil Clin N Am 
2005;16:91-108. 
 13.  Kohut ML, McCann DA, Russell DW, et al. Aerobic exercise, but not flexibility/resistance 
exercise, reduces serum IL-18, CRP, and IL-6 independent of [beta]-blockers, BMI, and 
psychosocial factors in older adults. Brain Behav Immun 2006;20:201-209. 
 14.  Resnick HE, Carter EA, Aloia M, et al. Cross-sectional relationship of reported fatigue to obesity, 
diet, and physical activity: results from the third national health and nutrition examination survey. J 
Clin Sleep Med 2006;2:163-169. 
37 
 15.  Puetz TW, Flowers SS, O'Connor PJ. A randomized controlled trial of the effect of aerobic exercise 
training on feelings of energy and fatigue in sedentary young adults with persistent fatigue. 
Psychother Psychosom 2008;77:167-174. 
 16.  Luctkar-Flude MF, Groll DL, Tranmer JE, et al. Fatigue and physical activity in older adults with 
cancer: a systematic review of the literature. Cancer Nurs 2007;30:E35-E45. 
 17.  Lee DC, Sui X, Blair SN. Does physical activity ameliorate the health hazards of obesity? Br J 
Sports Med 2009;43:49-51. 
 18.  Washburn RA, McAuley E, Katula J, et al. The Physical Activity Scale for the Elderly (PASE): 
Evidence for validity. J Clin Epidemiol 1999;52:643-651. 
 19.  Masse LC, Fuemmeler BF, Anderson CB, et al. Accelerometer data reduction: A comparison of 
four reduction algorithms on selected outcome variables. Med Sci Sports Exerc 2005;37:S544-
S554. 
 20.  Smets EMA, Garssen B, Bonke B, et al. The Multidimensional Fatigue Inventory (MFI); 
Psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315-325. 
 21.  Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument 
for psychiatric practice and research. Psychiatry Res 1989;28:193-213. 
 22.  Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression 
screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49. 
 23.  Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Spacapan 
S, Oskamp S, eds. The social psychology of health: Claremont Symposium on applied social 
psychology 1998, pp 31-67. 
 24.  Dantzer R, Capuron L, Irwin MR, et al. Identification and treatment of symptoms associated with 
inflammation in medically ill patients. Psychoneuroendocrinology 2008;33:18-29. 
 25.  van Mens-Verhulst J, Bensing JM. Sex differences in persistent fatigue. Women Health 
1997;26:51-70. 
 26.  Lim W, Hong S, Nelesen R, et al. The association of obesity, cytokine levels, and depressive 
symptoms with diverse measures of fatigue in healthy subjects. Arch Intern Med 2005;165:910-
915. 
 27.  Corwin EJ, Klein LC, Rickelman K. Predictors of fatigue in healthy young adults: Moderating 
effects of cigarette smoking and gender. Biol Res Nurs 2002;3:222-233. 
 28.  Alexander NB, Taffet GE, Horne FM, et al. Bedside-to-Bench Conference: Research agenda for 
idiopathic fatigue and aging. J Am Geriatr Soc 2010;58:967-975. 
38 
 29.  Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and 
immunity. Nat Rev Immunol 2006;6:772-783. 
 30.  Keaney JF, Jr., Larson MG, Vasan RS, et al. Obesity and systemic oxidative stress: Clinical 
correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 
2003;23:434-439. 
 31.  Hojlund K, Mogensen M, Sahlin K, et al. Mitochondrial dysfunction in type 2 diabetes and obesity. 
Endocrinol Metab Clin North Am 2008;37:713-731. 
 32.  Ko Su, Stenholm S, Ferrucci L. Characteristic gait patterns in older adults with obesity--Results 
from the Baltimore Longitudinal Study of Aging. J Biomech 2010;43:1104-1110. 
 33.  Collado-Hidalgo A, Bower JE, Ganz PA, et al. Inflammatory biomarkers for persistent fatigue in 
breast cancer survivors. Clin Cancer Res 2006;12:2759-2766. 
 34.  Sorensen B, Streib JE, Strand M, et al. Complement activation in a model of chronic fatigue 
syndrome. J Allergy Clin Immunol 2003;112:397-403. 
 35.  Davis MC, Zautra AJ, Younger J, et al. Chronic stress and regulation of cellular markers of 
inflammation in rheumatoid arthritis: Implications for fatigue. Brain Behav Immun 2008;22:24-32. 
 36.  Cho HJ, Seeman TE, Bower JE, et al. Prospective association between C-reactive protein and 
fatigue in the Coronary Artery Risk Development in Young Adults Study. Biol Psychiatry 
2009;66:871-878. 
 37.  Hamer M, Molloy GJ, de Oliveira C, et al. Persistent depressive symptomatology and 
inflammation: To what extent do health behaviours and weight control mediate this relationship? 
Brain Behav Immun 2009;23:413-418. 
 38.  Valentine RJ, McAuley E, Vieira VJ, et al. Sex differences in the relationship between obesity, C-
reactive protein, physical activity, depression, sleep quality and fatigue in older adults. Brain Behav 
Immun 2009;23:643-648. 
 39.  Vestergaard S, Nayfield SG, Patel KV, et al. Fatigue in a representative population of older persons 
and its association with functional impairment, functional limitation, and disability. J Gerontol A 
Biol Sci Med Sci 2009;64:76-82. 
 40.  Reichert FF, Barros AJD, Domingues MR, et al. The role of perceived personal barriers to 
engagement in leisure-time physical activity. Am J Public Health 2007;97:515-519. 
 41.  McAuley E, White SM, Rogers LQ, et al. Physical activity and fatigue in breast cancer and 
multiple sclerosis: Psychosocial mechanisms. Psychosom Med 2010;72:88-96. 
39 
 42.  Stewart JC, Rand KL, Muldoon MF, et al. A prospective evaluation of the directionality of the 
depression-inflammation relationship. Brain Behav Immun 2009;23:936-944. 
 43.  Tak LM, Bakker SJL, Slaets JPJ, et al. Is high-sensitive C-reactive protein a biomarker for 
functional somatic symptoms? A population-based study. Brain Behav Immun 2009;23:1014-1019. 
 44.  Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular 
disease: application to clinical and public health practice: a statement for healthcare professionals 
from the Centers for Disease Control and Prevention and the American Heart Association. 
Circulation 2003;107:499-511. 
 45.  Shelton RC, Miller AH. Eating ourselves to death (and despair): The contribution of adiposity and 
inflammation to depression. Prog Neurobiol 2010;91:275-299. 
 46.  Castanon-Cervantes O, Wu M, Ehlen JC, et al. Dysregulation of inflammatory responses by chronic 
circadian disruption. J Immunol 2010;185:5796-5805. 
 47.  Irwin MR, Wang M, Ribeiro D, et al. Sleep loss activates cellular inflammatory signaling. Biol 
Psychiatry 2008;64:538-540. 
 48.  Patel SR, Zhu X, Storfer-Isser A, et al. Sleep duration and biomarkers of inflammation. Sleep 
2009;32:200-204. 
 49.  Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev 
Immunol 2005;5:243-251. 
 50.  Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when 
the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56. 
 
 
40 
Table 3.1 Subject Characteristics 
Characteristics Women (N=84) Men (N=98) All (N=182) 
Age (years) 69.6±6.5 68.9±6.8 69.2±6.7 
Height (m) 1.6±0.6 1.8±0.7* 1.7±0.9 
Weight (kg) 70.3±14.2 84.0±14.8* 77.7±16.0 
BMI (kg/m2 26.7±5.2 ) 27.1±4.5 26.9±4.8 
Body Fat (%) 37.8±6.6 26.3±5.7* 31.6±8.4 
PASE 147.5±71.0 
1 161.9±73.6 155.1±72.6 
CRP (mg/l) 3.0±3.2 2.1±2.3 2.5±2.8 
IL-6 (pg/ml) 1.8±1.1 1.9±1.7 1.9±1.4 
sIL-6R (ng/ml) 49.0±13.7 42.2±10.7* 45.3±12.6 
WBC (k/µl) 5.4±1.4 5.6±1.5 5.5±1.4 
Activity (Counts/min) 269±110 
† 322±131* 297±124 
Psychosocial Measures    
General Fatigue 8.6±3.3 
2 8.3±3.2 8.4±3.3 
Physical Fatigue 8.5+3.4 8.4±3.4 8.4±3.4 
Reduced Activity 8.6±3.3 8.8±3.5 8.7±3.4 
Reduced Motivation 7.0±2.6 7.1±2.7 7.1±2.7 
Mental Fatigue 8.6±3.5 7.6±2.9* 8.1±3.2 
Pittsburg Sleep Quality Index 5.2±3.5 
3 5.0±3.1 5.1±3.2 
Geriatric Depression Scale 4.3±4.2 
4 3.8±4.6 4.1±4.4 
Perceived Stress Scale 10.5±6.0 
5 9.4±5.3 9.9±5.6 
*Sex difference (p<0.05). †N=165 for valid data. 
1 Physical Activity Scale for the Elderly. 2 Multidimensional Fatigue Inventory subscales range from 4-
20, with higher scores indicating higher levels of fatigue. 3 The Pittsburgh Sleep Quality Index ranges 
from 0-21, higher scores reflecting poorer sleep quality. 4 The Geriatric Depression Scale ranges from 0-
30, with higher scores corresponding to greater levels of depression. 5 The Perceived Stress Scale ranges 
from 0-40, with higher scores representing a higher level of stress. 
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Table 3.2 Prevalence of co-morbidities and medication usage 
Characteristics Women  
N (%) 
Men 
N (%) 
All 
N (%) 
Co-morbidities    
CVD 4 (5%) 1 15 (15%)* 19 (10%) 
Rhythm Disorders 9 (11%) 5 (5%) 14 (8%) 
Pulmonary Disease 6 (7%) 4 (4%) 10 (5%) 
Sleep Apnea 5 (6%) 10 (10%) 15 (8%) 
Diabetes 2 (2%) 9 (9%) 11 (6%) 
Arthritis 51 (61%) 42 (43%)* 93 (51%) 
Cancer History 13 (16%) 24 (25%) 37 (20%) 
Anemia 1 (1%) 4 (4%) 5 (3%) 
Medications    
Aspirin 32 (38%) 58 (59%)* 90 (49%) 
NSAIDs 16 (19%) 14 (14%) 30 (16%) 
Anti-hypertensives 34 (40%) 35 (36%) 69 (38%) 
     β-blockers 13 (15%) 14 (14%) 27 (15%) 
     Calcium-channel blockers 7 (8%) 11 (11%) 18 (9%) 
Statins 24 (28%) 47 (48%)* 71 (39%) 
Anti-depressants 12 (14%) 11 (11%) 23 (13%) 
     SSRIs 6 (7%) 6 (6%) 12 (7%) 
Thyroid 18 (21%) 6 (6%)* 24 (13%) 
*Sex difference (p<0.05). 
1
SSRIs – selective serotonin reuptake inhibitors
 Cardiovascular disease included history of myocardial infarction, bypass surgery, or other treatment 
(such as stent placement). 
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Table 3.3 Relation between adiposity, physical activity, inflammation, psychosocial variables and fatigue 
in older adults.  
 
 General 
Fatigue 
Physical 
Fatigue 
Reduced 
Activity 
Reduced 
Motivation 
Mental 
Fatigue 
Age 0.108 0.083 0.276* 0.156 0.092 
BMI 0.209* 0.340* 0.224* 0.142 0.031 
%Fat 0.248* 0.423* 0.329* 0.199* -0.029 
PASE -0.279* -0.367* -0.320* -0.221* -0.047 
Activity -0.209* -0.353* -0.318* -0.181* 0.146 
CRP 0.170* 0.212* 0.104 0.153* 0.062 
IL-6 0.194* 0.258* 0.211* 0.129 -0.025 
sIL-6R 0.029 0.101 0.03 0.019 -0.046 
WBC 0.147 0.223* 0.154 0.213* -0.104 
PSQI 0.528* 0.383* 0.282* 0.340* 0.161 
GDS 0.430* 0.402* 0.385* 0.451* 0.368* 
PSS 0.384* 0.306* 0.273* 0.379* 0.367* 
* Significant correlation at p < 0.05. 
All correlations controlled for age and sex (age-correlations controlled for sex). 
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Table 3.4 Relations between physiologic and psychosocial variables 
  %Fat PSQI GDS PSS CRP IL-6 sIL-6R WBC 
PASE -0.304* -0.084 -0.175* -0.047 -0.141 -0.187* 0.011 -0.203* 
Activity -0.385* -0.158 -0.139 -0.077 -0.106 -0.069 -0.087 -0.306* 
BMI 0.730* 0.066 -0.081 0.073 0.320* 0.311* 0.154* 0.347* 
%Fat  0.037 0.062 0.052 0.413* 0.351* 0.113 0.404* 
PSQI   0.306* 0.326* 0.006 -0.008 0.094 0.193* 
GDS    0.616* 0.026 -0.006 0.035 0.021 
PSS     0.033 0.120 -0.008 0.180* 
CRP      0.452* -0.119 0.274* 
IL-6       <0.001 0.378* 
sIL-6R        0.152 
* Significant correlation at p < 0.05. 
All correlations controlled for age and sex. 
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Table 3.5 Linear regression analyses of independent predictors of fatigue 
Subscale R R ∆F 2 Significance, 
∆F Variables β P Value 
General Fatigue        
     F 17,135
     P < 0.001 
 = 6.378 0.667 0.445 6.378 <0.001 Sex 
PSQI 
GDS 
%Fat 
0.205 
0.428 
0.250 
0.301 
0.045 
<0.001 
0.006 
0.011 
Physical Fatigue        
     F 17,135
     P < 0.001 
 = 6.250 0.664 0.440 6.250 <0.001 Sex 
PSQI 
GDS 
%Fat 
0.318 
0.188 
0.363 
0.459 
0.002 
0.010 
<0.001 
<0.001 
Reduced Activity        
     F 17,135
     P < 0.001 
 = 4.715 0.610 0.294 4.715 <0.001 Sex 
Age 
PSQI 
GDS 
%Fat 
0.299 
0.192 
0.151 
0.317 
0.351 
0.006 
0.020 
0.050 
0.001 
0.006 
Reduced Motivation        
     F 17,135
     P < 0.001 
 = 3.515 0.554 0.307 3.515 <0.001 PSQI 
GDS 
0.174 
0.346 
0.032 
0.001 
        
Mental Fatigue        
     F 17,135
     P < 0.001 
 = 3.301 0.542 0.292 3.301 <0.001 Age 
Statins 
GDS 
Activity 
0.183 
0.178 
0.290 
0.250 
0.036 
0.034 
0.004 
0.007 
All regression analyses were run in the following order: Step 1, age and sex; Step 2, medications (anti-
inflammatories, statins, β-blockers, calcium channel blockers, and SSRIs); Step 3, number of co-morbidities; 
Step 4, psychosocial variables (PSQI, GDS, PSS); Step 5, activity (accelerometer counts/min) and adiposity 
(%Fat); Step 6, inflammatory markers (CRP, IL-6, sIL-6R, WBC). 
 
General Fatigue: At Step 1, entering age and sex, R2 = 0.011. Step 2, entering medications, R2 = 0.045. Step 3, 
entering the number of co-morbidities, R2 = 0.108. Step 4, entering psychosocial variables, R2 = 0.398. Step 5, 
entering activity counts and %Fat, R2 = 0.441. Step 6, entering inflammation, R2
 
 = 0.445. 
Physical Fatigue: At Step 1, entering age and sex, R2 = 0.011. Step 2, entering medications, R2 = 0.072. Step 3, 
entering the number of co-morbidities, R2 = 0.112. Step 4, entering psychosocial variables, R2 = 0.300. Step 5, 
entering activity counts and %Fat, R2 = 0.437. Step 6, entering inflammation, R2
 
 = 0.440. 
Reduced Activity: At Step 1, entering age and sex, R2 = 0.088. Step 2, entering medications, R2 = 0.133. Step 
3, entering the number of co-morbidities, R2 = 0.143. Step 4, entering psychosocial variables, R2 = 0.285. Step 
5, entering activity counts and %Fat, R2 = 0.366. Step 6, entering inflammation, R2
 
 = 0.373. 
Reduced Motivation: At Step 1, entering age and sex, R2 = 0.037. Step 2, entering medications, R2 = 0.083. 
Step 3, entering the number of co-morbidities, R2 = 0.087. Step 4, entering psychosocial variables, R2 = 0.275. 
Step 5, entering activity counts and %Fat, R2 = 0.294. Step 6, entering inflammation, R2
 
 = 0.307. 
Mental Fatigue: At Step 1, entering age and sex, R2 = 0.047. Step 2, entering medications, R2 = 0.101. Step 3, 
entering the number of co-morbidities, R2 = 0.102. Step 4, entering psychosocial variables, R2 = 0.227. Step 5, 
entering activity counts and %Fat, R2 = 0.274. Step 6, entering inflammation, R2 = 0.294. 
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Figure 3.1 The interactive and main effects of adiposity and activity status on (A) general fatigue, (B) 
physical fatigue and (C) reduced activity. Values are displayed as mean±SEM. Numbers inside of bars 
represent the number of participants falling into each category, which is consistent across dimension of 
fatigue. * Indicates a significant difference from the high-activity/normal-weight group (p < 0.05).  
†
 
 Indicates a significant difference from the low-activity/over-weight group (p<0.05). 
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Figure 3.2 C-reactive protein (CRP) (A) and Interleukin-6 (IL-6) (B) in older adults reporting higher 
levels of general fatigue compared to those reporting low levels of fatigue. Mean±SEM.  
* Indicates a significant difference from the low-fatigued group (p < 0.05). 
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CHAPTER 4 
Body Composition and Habitual Physical Activity Are Related with  
Performance Measures of Physical Function in Community-Dwelling Older  Adults 
 
Abstract 
Aging is accompanied by gains in adiposity, loss of lean mass, reductions in physical activity, and loss of 
physical function. Purpose: The primary purpose of this study was to determine the influence of body 
composition components [adiposity and mineral-free lean mass (MFLM)] and physical activity (PA) on 
measures of lower-extremity physical function (LEPF) in community-dwelling older adults. Methods: 
Older adults (N=156, age=68.9±6.7 years, 85 men) were assessed for adiposity (% Fat) and lean mass 
[MFLMLEG and Skeletal Muscle Index (SMI); appendicular MFLM/ht2
 
] via dual-energy X-ray 
absorptiometry, and PA using accelerometers. LEPF was assessed by 7-m walk tests (WALK), a Timed 
Up and Go (Up&Go), a 30-second chair stand test (30-Chair), a 6-min walk, the Short Physical 
Performance Battery (SPPB) and the Star-Excursion Balance Test (STAR). Results: Men performed 
better on all LEPF tests (all p<0.05). MFLM and SMI were not related to any LEPF outcomes. In the 
absence of a significant interaction, main effects for adiposity were found for mobility tests of LEPF, 
including WALK, Up&Go, 30-Chair and 6-min walk with higher adiposity relating to poorer 
performance. There was a main effect of PA on 6-min walk only with greater PA conferring better 
performance. After accounting for influences of sex, age and number of co-morbidities, % Fat remained a 
significant predictor of all mobility measures and the STAR composite, as did PA for Up&Go and 6-min 
walk (all p < 0.05). Conclusion: Our results suggest that adiposity is a major determinant of both balance 
and gait-related physical function in relatively healthy older adults. Daily physical activity may help to 
prevent age-related loss of mobility. 
Key Words:  adiposity, lean mass, physical activity, function, mobility 
48 
4.1  Introduction 
The aging process is accompanied by a progressive reduction in lean mass, increases in total 
adipose tissue, and increased ectopic adipose, including visceral and accumulation of lipid infiltration into 
the muscle, especially after menopause in women (1;2). These changes in body composition are 
accompanied by progressive detriments in physical function with aging. Unfortunately, these alterations 
in body composition and fat distribution are commonly masked when assessed by BMI as often no 
substantial change, if any, in BMI appears, due to a reduction in muscle mass that accompanies the 
increase in fat mass (3). A number of studies have demonstrated an increased discrepancy between BMI 
and %Fat in the aging population (4).  
A rapidly growing public health concern in the aging population is a decrement in physical 
function. Reductions in physical function are associated with several adverse health outcomes, including 
further disability, fall risk, loss of independence, and mortality (5-8). Higher levels of adiposity have been 
linked to reductions in lower-extremity physical function (LEPF), limited mobility (9) and elevated risk 
for physical disability in older adults (10). This finding is inconsistent, as other reports support a role of 
reduced lean mass, particularly in the lower-body, rather than accumulation of fat mass as the primary 
determinant of functional ability (11-13). The influences of body composition components in relation to 
physical function are not well characterized. It is intuitive that the interaction between reduced skeletal 
muscle mass and increased adiposity may have the most impact on physical function. Lower levels of 
muscle mass may not be problematic if the load being carried (i.e., total body mass) is relatively low as 
well (14). On the other end of the spectrum, an individual with a high level of muscle mass, but a 
disproportionately elevated total body mass will likely have detriments in function. The somatotype at 
greatest risk for disability is a frail obese individual (relatively low levels of muscle mass in combination 
with elevated fat mass), which unfortunately represents a rapidly growing portion of the population (15). 
There is speculation that physical inactivity may provide a more direct link between elevated 
adiposity, reduced muscle mass and functional decline (16). Physical activity has been consistently 
associated with improvements in physical function (17;18). These benefits manifest as both a prolonged 
time until mobility disability occurs in the lifespan as well as improvements in functional testing scores. 
For example, physical activity has been shown to improve status [assessed via the short physical 
performance battery (SPPB)] scores by >1 point which has been supported as a clinically meaningful 
improvement in physical function (19). Some evidence suggests that moderate-to-vigorous physical 
activity may be required to maintain and/or improve physical function with aging (17;18;20).  
The interactive effects of physical activity and adiposity on physical function are less clear. 
Studies evaluating the relationship between physical activity and function often statistically account for 
body composition, in the form of BMI, and may be overlooking an important determinant involved in 
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function. A better understanding of the influence of physical activity on function, particularly in obese 
individuals at increased risk of disability, is warranted. In this context, the primary aim of this study was 
to determine the relative influences of disordered body composition (i.e., increases in adiposity relative to 
loss of muscle mass) and objectively measured physical activity on performance measures of physical 
function in relatively healthy older men and women.  
 
4.2  Materials and Methods 
 Participants 
One hundred fifty-six community-dwelling older adults (71 women, 85 men, 68.9±6.7 years) 
participated in this study. Exclusion criteria included the presence of severe arthritis, human 
immunodeficiency virus, smoking, current diagnoses of inflammatory disease or cancer, uncontrolled 
metabolic or cardiovascular disease. Individuals with neurologic diseases or severe orthopedic problems 
at the time of recruitment were also excluded. Following eligibility screening all participants completed a 
university Institutional Review Board approved informed consent prior to enrollment in the study. 
 
 Physical Activity 
 Accelerometers (ActiGraph single-axis model, Health One Technology) were used to provide an 
objective measure of physical activity over 1 week. Participants were instructed to wear the monitor on 
the non-dominant hip, under clothing, and fastened to a belt worn around the waist during waking hours. 
Data were recorded and stored in 1-minute epochs. It was required that participants had five valid days of 
data for a reliable estimate of weekly physical activity. Valid days for accelerometer data were 
determined by 10 hours of wear time during the waking hours (21), defined as the moment upon getting 
out of bed in the morning through the moment of getting into bed in the evening. We considered the data 
to be spurious when counts exceed 20,000 per minute (21). 
 
 Body Composition 
 Standing height and weight measurements were completed with subjects wearing light-weight 
clothing and no shoes. Height was obtained using a stadiometer (Seca, Model 242) with measures 
obtained to the nearest 0.1 cm. Weight was measured on a calibrated digital scale (Tanita, Model BWB-
627A). Body Mass Index (BMI) was calculated by dividing body mass (kg) by height (m) squared 
(kg/m2). Whole-body and regional soft tissue composition was measured by DXA using a Hologic 
Discovery A bone densitometer (software version 12.7.3). Regional analyses were performed per 
manufacturer guidelines and involved bisecting the femoral neck to determine mineral-free lean mass 
(MFLM) of the legs, and the gleno-humeral joint to determine MFLM of the arms. The MFLM of the 
50 
arms and legs was summed to provide a measure of appendicular lean mass, which was then normalized 
by height (kg/m2
 
), similar to BMI to provide a skeletal muscle index (SMI). Precision for DXA 
measurements of interest are 1-1.5% in our laboratory.  
 Lower-Extremity Physical Function 
 A series of physical performance tests were administered to evaluate lower-extremity physical 
function (LEPF). The Short Physical Performance Battery (SPPB) was used to objectively evaluate 
physical function. This 3 item performance test consists of a combination of tests including balance, gait 
speed and chair stands that correlate well with degree of disability, loss of independence and mortality, 
and with other objective measures of strength and balance (22). Functional gait tests included a series of 
7-meter walks, performed at normal walking speed (WALK), and as quickly as possible (FASTWALK). 
Each participant completed two trials of 7-m walks for both conditions. Participants also completed a 
timed up-and-go (UPGO) as quickly as possible. On the command “go” participants were told to stand 
from a chair, walk around a cone placed 2.5 m away and return to the chair and sit down, while being 
timed. Similarly, participants completed a series of as many repeated chair stands as possible over a 30-
second period (CHAIR-30). Finally, a 6-minute walk was used as a measure of functional endurance 
which has been shown to be useful and clinically meaningful in this population.  
 
Balance 
 The Star-Excursion Balance Test (STAR), also known as the Lower-Extremity Reach Test 
(LERT), was performed to challenge unilateral dynamic balance (23). This test involved balancing on a 
stance leg and reaching with the opposite leg as far as possible. Participants were instructed to maintain 
hands on hips and were not allowed to shift their weight from the stance leg. Following several 
familiarization trials, 5 reaches were completed in the anterior, medial, and posterior directions (in 
reference to the stance leg) (23), and the distance from the heel of the stance foot to the distal touch point 
of each was recorded. Reach distances were normalized to leg length of the reach leg. This distance 
reflects dynamic balance of each limb (23). 
  
 Statistical Analyses 
Data were analyzed with PASW for Windows version 18.0 (SPSS, Inc., Chicago IL). Means and 
standard deviations were calculated for all participant characteristics and primary outcome variables, and 
distribution statistics were computed to ensure data were normally distributed. Independent samples t-
tests were conducted to determine sex differences. Partial correlations, controlling for sex and age, were 
conducted to examine the associations among variables of interest. A series of hierarchical linear 
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regression analyses were conducted to assess the independent contributions of adiposity, MFLMLEG
 
, and 
physical activity on physical function. Due to known differences between men and women (e.g. adiposity, 
physical activity and function), all analyses were controlled for sex and age. Additionally, we categorized 
subjects based upon adiposity categories according to World Health Organization cut-points for older 
adults for women and men, respectively: healthy fat (24-35.9% and 13-24.9%), over-fat (36-41.9% and 
25-29.9%) and obese (>42% and >30%) (24). Using the median value for activity counts, high- and low-
activity groups were created. To determine the presence of an interaction of PA and adiposity on function, 
as well as main effects of each, a two-way ANCOVA, adjusting for age and sex was performed. Analysis 
of variance (ANOVA), with post hoc Tukey, was performed to assess differences in function between 
activity-fatness groups. All significance tests were conducted at the p ≤ .05 level.  
4.3  Results 
 Characteristics of participants are presented in Table 4.1. Men were taller and weighed more than 
women. Although similar in BMI and activity levels, women had significantly higher %Fat, and lower 
MFLM corresponding to a lower skeletal muscle index (SMI). Men were more active than women for 
total activity, but did not engage in more moderate-to-vigorous physical activity (MVPA). In regard to co-
morbidities, women reported a higher prevalence of arthritis, with no other sex differences. On functional 
tasks, men performed better than women on the 7-meter fast walk (7m FAST), the Up&Go, the 6-min 
walk, and the SPPB composite score (Table 4.2; all p < 0.05). On balance tests, men performed better on 
the medial reach only (p = 0.04), with posterior and composite reaches failing to reach significance (p = 
0.08 and p = 0.06, respectively) compared to women.  
 Adiposity was inversely associated with all measures of physical function (r range = 0.20 to 
0.44), however no measure of lean mass (MFLM, MFLMLEG
Results comparing function measures across PA-fatness groups are shown in Figure 4.1. There 
was an interaction between PA and adiposity for only the 30-second chair stand test of the gait-related 
functional tasks. In the absence of other interactions, there was a main effect of adiposity on several 
functional tests, including WALK, UP&GO, 5-rep chair-stand, and 6-min walk (all p < 0.05). In contrast, 
there was a main effect of activity on the 6-min walk only (p = 0.03). With regard to balance tests, there 
was an interaction on medial, posterior and composite reach distances (interaction p < 0.05, see Figure 
4.2). There was a main effect of adiposity on anterior reach distance (p = 0.02). 
, or SMI) correlated with any functional 
measure (Table 4.3). Higher total activity counts were related to better physical function on walking tasks 
(r range = 0.19 to 0.36), but not chair rise tasks (p > 0.05). MVPA was only related to distance covered on 
the 6-min walk test (r = 0.25, p < 0.01).  
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 Regression analyses were performed to examine the independent contribution %Fat, MFLMLEG 
and physical activity to physical function (Table 4.4). After controlling for age, sex, and number of co-
morbidities, %Fat remained a significant predictor of Up&Go, Chair-stand (both 5-rep and 30-second), 6-
min walk, and balance performance. Physical activity was an independent predictor of the Up&Go and 6-
min walk. MFLMLEG
 
 did not significantly contribute to the model for any outcome of performance, and 
when replaced with other measures of lean mass (total MFLM or SMI) this result did not change. When 
total PA was replaced with time spent in MVPA there was an independent contribution of MVPA on the 
6-min walk test only (data not shown). 
4.4  Discussion 
The results from the present study support a detrimental role of adiposity on physical function in 
aging men and women. We add to the mounting literature aiming to uncover the etiological factors 
influencing physical functional limitations in older adults. In particular, our data support adiposity, rather 
than lean mass as the more deleterious body composition component affecting function. Several 
investigations have corroborated a relationship between BMI and performance on functional tasks, 
including the 6-min walk and 400-m walks. However, given the discordance between BMI and adiposity 
in the aging population and in individuals most at risk for mobility limitations in particular, we suggest 
the increasing importance of measuring adiposity rather than using BMI as a surrogate. Our data 
underscores the importance of utilizing measures of adiposity as this field of study evolves.  
The findings in the current study expand on the current literature, attempting to characterize the 
physical function ability of a growing population of overweight and obese older adults (9). The most 
intuitive reason for this decline in physical function with obesity is the physical burden of carrying an 
excess load, which is typically accompanied by minimal increases (if any) in muscle mass or strength. 
Similarly, obesity is associated with biomechanical changes in gait (25), which likely is a cause and 
consequence of mobility disability. This may be at least partially explained by the added energy 
requirement to complete a given task, particularly as accumulating activities of daily living deplete energy 
stores throughout the day (26).  
The clear robust effect of adiposity on physical function has been largely overlooked in studies 
investigating the relationship between PA and function. This becomes increasingly important given the 
growing population of overweight and obese older adults. Limited objective exercise intensity data in 
regard to physical function are available. A recent report from Chale-Rush and colleagues, reported for 
the first time individuals reporting greater than 150 min/week of MVPA (as captured by self-report) 
perform better on physical performance tasks, including the SPPB and 400m walk (20).  Of note, that 
study was limited to individuals at risk for mobility disability (SPPB < 10), and MVPA activity groups 
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were divided based on 150 min/wk of MVPA (20). In the current study the median split for objectively 
measured MVPA was < 60min/wk, substantially lower than that previously used. Our data support 
increases in total activity to be related to physical function performance, with no added benefit of MVPA. 
Perhaps setting the MVPA activity categories at a higher level of accumulating activity would allow for 
the functional differences to be seen. These findings that total, or light activity appear to be sufficient for 
higher scores of function are consistent with others using objectively measured PA (17;27;28). Our 
findings extend the previous relations of activity with the SPPB to additional measures of function, 
including the Up&Go, 6-min walk and dynamic balance tests in both men and women. In contrast to the 
majority of studies investigating the relations between physical activity and function, which have been 
limited to sedentary populations, we targeted recruitment to obtain a wide array of activity levels in order 
to gain a better understanding of varying levels of activity and functional decline.  
Prospective studies have identified an association between physical activity and attenuation in 
muscle mass loss and preservation of muscle strength and function (29). Limited work has been done to 
identify intensity-specific associations between habitual physical activity and reductions in functional 
decline. However, loss of muscle strength, rather than lean mass per se, appears to be a more important 
determinant of function (30). Additionally, the relationship between physical activity and muscle quality, 
or strength per muscle mass, may also play a role in regard to the decline in function seen with age (31). 
Aging is associated with reductions in muscle quality (strength normalized per muscle size or mass), in 
addition to declines in strength or mass alone, and leg muscle quality is an important factor for physical 
function in obese frail elderly (32). Increases in obesity status are also associated with poorer muscle 
quality (33). Thus, age-related changes in adiposity, physical activity and muscle quality may all impact 
obesity-related mobility impairments. Development of treatment strategies to attenuate declines in 
function is imperative, as the prevalence of obesity-related disability continues to grow rapidly, with 
estimates suggesting > 40% of obese individuals reporting functional impairment (34).  
The present study is not without limitations. The current population included a wide variety of 
physical activity, body composition, and functional ability levels, and may not reflect the relationships 
that may be present in more disabled populations. It should be noted, that our study sample is similar in 
obesity and co-morbidity prevalence to that of the general population. We believe this may provide a 
framework for the initial phases of the disablement process (19) and is relevant in regard to prevention of 
mobility disability. In creating the activity sub-groups, there is no consensus for clear cut-points in the 
older adults and we relied on median splits for high- and low-activity groups. Identification of a threshold 
effect, whereby accumulation of a set quantity of physical activity is necessary for achieving functional 
benefits has not been established. Using recognized MVPA cut-offs (> 150 min/wk) for other health 
benefits (35), our high-activity sample was limited to 43 participants (26%). Given that the population in 
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the current study was relatively health and community-dwelling, yet such a small portion accumulating > 
150 min/wk of MVPA this may not be an appropriate cut-off, particularly when studying more disabled 
or mobility-limited populations. 
In conclusion, reductions in adiposity, rather than focusing on gains in lean mass, appear to be a 
worthwhile target to maintain, or possibly regain, mobility in older adults. As a behavioral therapy, 
physical activity may have direct and indirect benefits, via weight management and maintenance of 
muscle mass, strength, and quality. The quantity and intensity of physical activity required to obtain 
benefits in function are currently not established. Our data support increases in total activity to be related 
to physical function performance, with no added benefit of MVPA. This finding has great public health 
significance, as older adults can positively influence their physical function ability simply by increasing 
their daily activity levels, without the burden of high-intensity ‘training’. Due to the complexity of these 
relationships, future work should simultaneously assess each of these factors to further our understanding 
the disablement process. Uncovering the key influential factors contributing to disability is essential for 
development and implementation of effective prevention and treatment strategies for loss in mobility. 
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Table 4.1 Subject Characteristics 
Characteristics Women (N=71) Men (N=85) p-value 
Age (years) 69.1±6.2 68.8±8 0.837 
Height (m) 1.62±0.6 1.76±0.7 <0.001 
Weight (kg) 69.1±14.1 82.8±13.8 <0.001 
BMI (kg/m2 26.3±5.1 ) 26.7±3.9 0.570 
Body Fat (%) 37.4±6.9 26.2±5.6 <0.001 
SMI (kg/m2 6.5±1.0 ) 8.4±1.0 <0.001 
Activity counts (counts/min) 274.0±111.5 324.2±131.0 0.012 
MVPA (min/week) 79.6±96.8 104.1±123.1 0.175 
Co-morbidities    
Cardiovascular 4 (5%) 15 (15%) 0.055 
Respiratory or pulmonary 9 (11%) 5 (5%) 0.232 
Arthritis 6 (7%) 4 (4%) 0.037 
Number of medical conditions 5 (6%) 10 (10%) 0.543 
Number of medications 2 (2%) 9 (9%) 0.097 
Means±SD are presented unless otherwise indicated. 
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Table 4.2 Lower-Extremity Physical Function Performance 
Dynamic Gait Women (N=71) Men (N=85) p-value 
7-meter Walk (sec) 5.34±1.09 5.28±0.94 0.704 
7-meter FastWalk (sec) 3.80±0.71 3.53±0.74 0.022 
Up&Go (sec) 6.31±1.78 5.72±1.59 0.030 
5-rep Chair Stand (sec) 8.58±2.68 7.65±2.97 0.050 
30-sec Chair Stand (reps) 15.72±4.13 17.51±5.89 0.035 
6-min walk (meters) 561±94 630±119 <0.001 
SPPB Total Score 11.47±1.03 11.6±1.2 0.369 
Balance    
Anterior Reach 1.72±0.19 1.75±0.17 0.344 
Medial Reach 1.52±0.20 1.59±0.25 0.037 
Posterior Reach 1.03±0.33 1.13±0.33 0.080 
Composite Reach 4.27±0.65 4.47±0.67 0.064 
Means±SD are presented unless otherwise indicated. 
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Table 4.3a Relation between adiposity, lean mass, physical activity and function in older adults. 
 WALK FASTWALK Up&Go 5-Rep Chair 
30-sec 
Chair 
6-min 
Walk 
SPPB 
Total 
Age .335* .383* .399* .385* -.361* -.550* -.360* 
%Fat .313* .287* .324* .284* -.386* -.458* -.219* 
MFLM .155 LEG .077 .092 .138 -.023 -.051 -.147 
SMI .184 .148 .081 .030 .035 -.165 -.103 
Activity Counts -.236* -.150 -.200* -.130 .163 .351* .181* 
MVPA -.177* -.134 -.099 -.073 .121 .288* .119 
* Significant correlation at p < 0.05. All analyses were controlled for age and sex (except for age, 
which is controlled for sex only). 
 
Table 4.3b Relation between adiposity, lean mass, physical activity and balance in older adults. 
 Anterior Medial Posterior Composite 
Age -.271* -.327* -.434* -.402* 
%Fat -.315* -.324* -.264* -.335* 
MFLM -.152 LEG -.064 -.040 -.086 
SMI -.156 -.092 -.056 -.106 
Activity Counts  .218* .234* .177* .232* 
MVPA .198* .140 .182* .196* 
* Significant correlation at p < 0.05. All analyses were controlled for age and sex. (except for 
age, which is controlled for sex only). 
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Table 4.4 Linear regression analyses of independent predictors of physical function 
Subscale R R ∆F 2 Significance, 
∆F Variables β P Value 
Up&Go        
     F 6, 158
     P < 0.001 
 = 12.081 0.561 0.314 12.081 <0.001 Sex 
Age 
Co-morbidites 
%Fat 
Activity 
MFLM
0.032 
LEG 
0.394 
-0.035 
0.305 
-0.190 
0.072 
0.795 
<0.001 
0.608 
0.003 
0.018 
0.486 
5-rep Chair Stand        
     F 6,156
     P < 0.001 
 = 12.106 0.495 0.245 12.106 <0.001 Sex 
Age 
Co-morbidites 
%Fat 
Activity 
MFLM
-0.082 
LEG 
0.404 
0.019 
0.254 
-0.087 
0.183 
0.551 
<0.001 
0.800 
0.021 
0.320 
0.111 
30-second Chair Stand        
     F 6,161
     P < 0.001 
 = 9.787 0.524 0.275 9.787 <0.001 Sex 
Age 
Co-morbidites 
%Fat 
Activity 
MFLM
-0.114 
LEG 
-0.363 
-0.049 
-0.424 
0.064 
-0.019 
0.373 
<0.001 
0.496 
<0.001 
0.437 
0.862 
6-min Walk        
     F 6,146
     P < 0.001 
 = 25.819 0.725 0.525 25.819 <0.001 Sex 
Age 
Co-morbidites 
%Fat 
Activity 
MFLM
0.007 
LEG 
-0.465 
-0.117 
-0.396 
0.183 
-0.010 
0.945 
<0.001 
0.058 
<0.001 
0.011 
0.907 
SPPB        
     F 6,155
     P < 0.001 
 = 7.383 0.479 0.229 7.383 <0.001 Sex 
Age 
Co-morbidites 
%Fat 
Activity 
MFLM
0.058 
LEG 
-0.368 
-0.079 
-0.185 
0.146 
-0.210 
0.681 
<0.001 
0.296 
0.098 
0.094 
0.074 
STAR Composite        
     F 6,159
     P < 0.001 
 = 11.734 0.561 0.315 11.734 <0.001 Sex 
Age 
Co-morbidites 
%Fat 
Activity 
MFLM
0.016 
LEG 
-0.358 
-0.162 
-0.293 
0.142 
-0.129 
0.902 
<0.001 
0.022 
0.005 
0.081 
0.215 
 
61 
Figure 4.1 The interactive effects of adiposity and physical activity on (A) Up&Go, (B) 5-Rep Chair Stand, (C) 30-sec Chair Stand, (D) 6-min 
walk and (E) SPPB total score. Numbers in bars represent the number of participants in each group. Values are presented as means and SE.  
* Significant difference from the healthy-fat/high-activity group (p < 0.05). †
 
 Significant difference from the obese/low-activity group (p <0.05). 
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Figure 4.2 The interactive effects of adiposity and physical activity on dynamic balance, including: (A) Anterior, (B) Medial, (C) Posterior and 
(D) Composite reach distances, normalized to leg length. Numbers in bars represent the number of participants in each group. Values are presented 
as means and SE. * Significant difference from the healthy-fat/high-activity group (p < 0.05). †
 
Significant difference from the obese/low-activity 
group (p < 0.05). 
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CHAPTER 5 
Summary and Discussion 
 
The results from the present study add to the rapidly accruing body of literature regarding the 
interactions between adiposity and physical activity on a multitude of health outcomes. The American 
demographics are progressing in concert with the rising prevalence of overweight, obesity and physical 
inactivity, each of which is increasing at an alarming rate. The aging process is accompanied by adverse 
alterations in body composition, reductions in muscle strength and function, and fatigue. The newly 
coined concept of inflamm-aging, and its role in the disablement process are only beginning to be fully 
understood. Chronic elevations in inflammatory mediators may have a causal role underpinning a variety 
of co-morbid states, including, but not limited to fatigue, sarcopenia, and physical dysfunction.  
Only recently is there becoming an appreciation for adipose tissue as an active endocrine organ 
rather than simply a storage depot. The impact of excess adiposity is widely underappreciated. Results 
from this study exemplify the contribution of adiposity on several aspects of adverse aging, including 
Fatigue in multiple domains, elevations in systemic inflammation and reductions in physical function. 
Additional research in this area should focus on the underlying connection between obesity and fatigue.  
Fortunately, physical activity is a modifiable behavior effective in treating a variety of health 
complications. Our data expand upon this, as being physically active appears to be beneficial for 
attenuating the obesity-associated perceptions of fatigue and detriments in physical function. Currently, 
recommendations regarding the quantity, intensity, and type of physical activity necessary to obtain the 
benefits on these specific outcomes have not been established. Future work should attempt to better define 
these activity thresholds. Results from our work suggest simply increasing daily activity levels may be 
sufficient in achieving the beneficial effects of exercise on fatigue and function, with no added benefit of 
higher intensity moderate-to-vigorous physical activity. 
Identification of psycho-physiological influences governing physical activity and obesity-related 
behaviors is a promising area of research. Results from this cross-sectional study are intended to inform 
longitudinal and mechanistic investigations aimed at attenuating inflammation, fatigue and physical 
dysfunction. Enhancing our understanding of aging associated decrements is essential for establishing 
prevention and treatment strategies targeted at inactivity, physical dysfunction toward the end of 
maximizing the quality of life across the lifespan and into old age. 
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